canvas 0.2.5__py3-none-any.whl → 0.2.11__py3-none-any.whl
This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
Potentially problematic release.
This version of canvas might be problematic. Click here for more details.
- {canvas-0.2.5.dist-info → canvas-0.2.11.dist-info}/METADATA +4 -1
- canvas-0.2.11.dist-info/RECORD +144 -0
- canvas_cli/apps/plugin/plugin.py +51 -9
- canvas_cli/apps/plugin/tests.py +51 -0
- canvas_cli/tests.py +193 -4
- canvas_cli/utils/validators/manifest_schema.py +1 -0
- canvas_generated/messages/effects_pb2.py +2 -2
- canvas_generated/messages/effects_pb2.pyi +136 -0
- canvas_generated/messages/events_pb2.py +3 -3
- canvas_generated/messages/events_pb2.pyi +614 -0
- canvas_sdk/__init__.py +7 -0
- canvas_sdk/base.py +6 -2
- canvas_sdk/commands/__init__.py +26 -0
- canvas_sdk/commands/base.py +35 -32
- canvas_sdk/commands/commands/allergy.py +49 -0
- canvas_sdk/commands/commands/assess.py +1 -1
- canvas_sdk/commands/commands/close_goal.py +22 -0
- canvas_sdk/commands/commands/diagnose.py +3 -3
- canvas_sdk/commands/commands/family_history.py +18 -0
- canvas_sdk/commands/commands/goal.py +3 -3
- canvas_sdk/commands/commands/history_present_illness.py +1 -1
- canvas_sdk/commands/commands/instruct.py +17 -0
- canvas_sdk/commands/commands/lab_order.py +33 -0
- canvas_sdk/commands/commands/medical_history.py +34 -0
- canvas_sdk/commands/commands/medication_statement.py +1 -1
- canvas_sdk/commands/commands/past_surgical_history.py +28 -0
- canvas_sdk/commands/commands/perform.py +17 -0
- canvas_sdk/commands/commands/plan.py +2 -2
- canvas_sdk/commands/commands/prescribe.py +10 -7
- canvas_sdk/commands/commands/questionnaire.py +1 -1
- canvas_sdk/commands/commands/refill.py +16 -0
- canvas_sdk/commands/commands/remove_allergy.py +26 -0
- canvas_sdk/commands/commands/stop_medication.py +1 -1
- canvas_sdk/commands/commands/task.py +52 -0
- canvas_sdk/commands/commands/update_diagnosis.py +27 -0
- canvas_sdk/commands/commands/update_goal.py +1 -1
- canvas_sdk/commands/commands/vitals.py +78 -0
- canvas_sdk/commands/constants.py +7 -0
- canvas_sdk/commands/tests/protocol/__init__.py +0 -0
- canvas_sdk/commands/tests/protocol/tests.py +55 -0
- canvas_sdk/commands/tests/schema/__init__.py +0 -0
- canvas_sdk/commands/tests/schema/tests.py +104 -0
- canvas_sdk/commands/tests/test_utils.py +170 -6
- canvas_sdk/commands/tests/unit/__init__.py +0 -0
- canvas_sdk/commands/tests/{tests.py → unit/tests.py} +20 -194
- canvas_sdk/effects/banner_alert/add_banner_alert.py +8 -7
- canvas_sdk/effects/banner_alert/remove_banner_alert.py +3 -2
- canvas_sdk/effects/banner_alert/tests.py +224 -0
- canvas_sdk/effects/base.py +3 -5
- canvas_sdk/effects/patient_chart_summary_configuration.py +39 -0
- canvas_sdk/effects/protocol_card/__init__.py +1 -0
- canvas_sdk/effects/protocol_card/protocol_card.py +83 -0
- canvas_sdk/effects/protocol_card/tests.py +184 -0
- canvas_sdk/protocols/clinical_quality_measure.py +41 -0
- canvas_sdk/utils/db.py +17 -0
- canvas_sdk/v1/__init__.py +0 -0
- canvas_sdk/v1/data/__init__.py +3 -0
- canvas_sdk/v1/data/allergy_intolerance.py +63 -0
- canvas_sdk/v1/data/base.py +47 -0
- canvas_sdk/v1/data/condition.py +48 -0
- canvas_sdk/v1/data/lab.py +96 -0
- canvas_sdk/v1/data/medication.py +54 -0
- canvas_sdk/v1/data/patient.py +49 -0
- canvas_sdk/v1/data/user.py +10 -0
- canvas_sdk/value_set/tests/test_value_sets.py +65 -0
- canvas_sdk/value_set/v2022/adverse_event.py +33 -0
- canvas_sdk/value_set/v2022/allergy.py +232 -0
- canvas_sdk/value_set/v2022/assessment.py +215 -0
- canvas_sdk/value_set/v2022/communication.py +325 -0
- canvas_sdk/value_set/v2022/condition.py +40654 -0
- canvas_sdk/value_set/v2022/device.py +174 -0
- canvas_sdk/value_set/v2022/diagnostic_study.py +4967 -0
- canvas_sdk/value_set/v2022/encounter.py +2564 -0
- canvas_sdk/value_set/v2022/immunization.py +341 -0
- canvas_sdk/value_set/v2022/individual_characteristic.py +307 -0
- canvas_sdk/value_set/v2022/intervention.py +1356 -0
- canvas_sdk/value_set/v2022/laboratory_test.py +1250 -0
- canvas_sdk/value_set/v2022/medication.py +5130 -0
- canvas_sdk/value_set/v2022/physical_exam.py +201 -0
- canvas_sdk/value_set/v2022/procedure.py +4037 -0
- canvas_sdk/value_set/v2022/symptom.py +176 -0
- canvas_sdk/value_set/value_set.py +91 -0
- settings.py +43 -0
- canvas-0.2.5.dist-info/RECORD +0 -91
- {canvas-0.2.5.dist-info → canvas-0.2.11.dist-info}/WHEEL +0 -0
- {canvas-0.2.5.dist-info → canvas-0.2.11.dist-info}/entry_points.txt +0 -0
|
@@ -0,0 +1,1250 @@
|
|
|
1
|
+
from ..value_set import ValueSet
|
|
2
|
+
|
|
3
|
+
|
|
4
|
+
class AntiHepatitisAIggAntigenTest(ValueSet):
|
|
5
|
+
"""
|
|
6
|
+
**Clinical Focus:** The purpose of this value set is to represent concepts for the detection of anti Hepatitis A immunoglobulin (IgG) antibodies.
|
|
7
|
+
|
|
8
|
+
**Data Element Scope:** This value set may use a model element related to Laboratory Test.
|
|
9
|
+
|
|
10
|
+
**Inclusion Criteria:** Includes concepts that represent tests for the IgG antibody to Hepatitis A in serum.
|
|
11
|
+
|
|
12
|
+
**Exclusion Criteria:** Excludes concepts that represent an order only.
|
|
13
|
+
|
|
14
|
+
** Used in:** CMS117v10
|
|
15
|
+
"""
|
|
16
|
+
|
|
17
|
+
VALUE_SET_NAME = "Anti Hepatitis A IgG Antigen Test"
|
|
18
|
+
OID = "2.16.840.1.113883.3.464.1003.198.12.1033"
|
|
19
|
+
DEFINITION_VERSION = "20170504"
|
|
20
|
+
EXPANSION_VERSION = "eCQM Update 2021-05-06"
|
|
21
|
+
|
|
22
|
+
LOINC = {
|
|
23
|
+
"32018-4", # Hepatitis A virus IgG Ab [Presence] in Serum
|
|
24
|
+
"40724-7", # Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
|
|
25
|
+
"51913-2", # Hepatitis A virus IgG+IgM Ab [Presence] in Serum
|
|
26
|
+
}
|
|
27
|
+
|
|
28
|
+
|
|
29
|
+
class AntiHepatitisBVirusSurfaceAb(ValueSet):
|
|
30
|
+
"""
|
|
31
|
+
**Clinical Focus:** The purpose of this value set is to represent concepts for the detection of the anti Hepatitis B surface antigen.
|
|
32
|
+
|
|
33
|
+
**Data Element Scope:** This value set may use a model element related to Laboratory Test.
|
|
34
|
+
|
|
35
|
+
**Inclusion Criteria:** Includes concepts that represent tests for the anti-surface antibody to Hepatitis B virus in serum.
|
|
36
|
+
|
|
37
|
+
**Exclusion Criteria:** Excludes concepts that represent an order only.
|
|
38
|
+
|
|
39
|
+
** Used in:** CMS117v10
|
|
40
|
+
"""
|
|
41
|
+
|
|
42
|
+
VALUE_SET_NAME = "Anti Hepatitis B Virus Surface Ab"
|
|
43
|
+
OID = "2.16.840.1.113883.3.464.1003.198.12.1073"
|
|
44
|
+
DEFINITION_VERSION = "20170504"
|
|
45
|
+
EXPANSION_VERSION = "eCQM Update 2021-05-06"
|
|
46
|
+
|
|
47
|
+
LOINC = {
|
|
48
|
+
"10900-9", # Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay
|
|
49
|
+
"22322-2", # Hepatitis B virus surface Ab [Presence] in Serum
|
|
50
|
+
"39535-0", # Hepatitis B virus surface Ab [Presence] in Serum by Radioimmunoassay (RIA)
|
|
51
|
+
"48070-7", # Hepatitis B virus surface IgG Ab [Presence] in Serum by Immunoassay
|
|
52
|
+
"49177-9", # Hepatitis B virus surface IgG Ab [Presence] in Serum
|
|
53
|
+
"75409-3", # Hepatitis B virus surface Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
|
|
54
|
+
}
|
|
55
|
+
|
|
56
|
+
|
|
57
|
+
class MeaslesAntibodyTestIggAntibodyTiter(ValueSet):
|
|
58
|
+
"""
|
|
59
|
+
**Clinical Focus:** The purpose of this value set is to represent concepts for laboratory tests for the titer of measles IgG antibody.
|
|
60
|
+
|
|
61
|
+
**Data Element Scope:** This value set may use a model element related to Laboratory Test.
|
|
62
|
+
|
|
63
|
+
**Inclusion Criteria:** Includes concepts that represent tests for the measles IgG titer in serum or cerebrospinal fluid.
|
|
64
|
+
|
|
65
|
+
**Exclusion Criteria:** Excludes concepts that represent an order only.
|
|
66
|
+
|
|
67
|
+
** Used in:** CMS117v10
|
|
68
|
+
"""
|
|
69
|
+
|
|
70
|
+
VALUE_SET_NAME = "Measles Antibody Test (IgG Antibody Titer)"
|
|
71
|
+
OID = "2.16.840.1.113883.3.464.1003.198.12.1059"
|
|
72
|
+
DEFINITION_VERSION = "20170504"
|
|
73
|
+
EXPANSION_VERSION = "eCQM Update 2021-05-06"
|
|
74
|
+
|
|
75
|
+
LOINC = {
|
|
76
|
+
"21500-4", # Measles virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
|
|
77
|
+
"21501-2", # Measles virus IgG Ab [Titer] in Serum by Immunofluorescence
|
|
78
|
+
"22501-1", # Measles virus IgG Ab [Titer] in Cerebral spinal fluid
|
|
79
|
+
"22502-9", # Measles virus IgG Ab [Titer] in Serum
|
|
80
|
+
}
|
|
81
|
+
|
|
82
|
+
|
|
83
|
+
class MeaslesAntibodyTestIggAntibodyPresence(ValueSet):
|
|
84
|
+
"""
|
|
85
|
+
**Clinical Focus:** The purpose of this value set is to represent concepts for laboratory tests for the presence of measles IgG antibody.
|
|
86
|
+
|
|
87
|
+
**Data Element Scope:** This value set may use a model element related to Laboratory Test.
|
|
88
|
+
|
|
89
|
+
**Inclusion Criteria:** Includes concepts that represent tests for the presence of measles IgG in serum, cerebrospinal fluid or body fluid.
|
|
90
|
+
|
|
91
|
+
**Exclusion Criteria:** Excludes concepts that represent an order only.
|
|
92
|
+
|
|
93
|
+
** Used in:** CMS117v10
|
|
94
|
+
"""
|
|
95
|
+
|
|
96
|
+
VALUE_SET_NAME = "Measles Antibody Test (IgG Antibody presence)"
|
|
97
|
+
OID = "2.16.840.1.113883.3.464.1003.198.12.1060"
|
|
98
|
+
DEFINITION_VERSION = "20170504"
|
|
99
|
+
EXPANSION_VERSION = "eCQM Update 2021-05-06"
|
|
100
|
+
|
|
101
|
+
LOINC = {
|
|
102
|
+
"20479-2", # Measles virus IgG Ab [Presence] in Serum
|
|
103
|
+
"35275-7", # Measles virus IgG Ab [Presence] in Serum by Immunoassay
|
|
104
|
+
"40648-8", # Measles virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
|
|
105
|
+
"41132-2", # Measles virus IgG Ab [Presence] in Cerebral spinal fluid
|
|
106
|
+
"53536-9", # Measles virus IgG Ab [Presence] in Body fluid by Immunoassay
|
|
107
|
+
}
|
|
108
|
+
|
|
109
|
+
|
|
110
|
+
class MumpsAntibodyTestIggAntibodyTiter(ValueSet):
|
|
111
|
+
"""
|
|
112
|
+
**Clinical Focus:** The purpose of this value set is to represent concepts for laboratory tests for the titer of mumps IgG antibody.
|
|
113
|
+
|
|
114
|
+
**Data Element Scope:** This value set may use a model element related to Laboratory Test.
|
|
115
|
+
|
|
116
|
+
**Inclusion Criteria:** Includes concepts that represent tests for the mumps IgG titer in serum or cerebrospinal fluid.
|
|
117
|
+
|
|
118
|
+
**Exclusion Criteria:** Excludes concepts that represent an order only.
|
|
119
|
+
|
|
120
|
+
** Used in:** CMS117v10
|
|
121
|
+
"""
|
|
122
|
+
|
|
123
|
+
VALUE_SET_NAME = "Mumps Antibody Test (IgG Antibody Titer)"
|
|
124
|
+
OID = "2.16.840.1.113883.3.464.1003.198.12.1061"
|
|
125
|
+
DEFINITION_VERSION = "20170504"
|
|
126
|
+
EXPANSION_VERSION = "eCQM Update 2021-05-06"
|
|
127
|
+
|
|
128
|
+
LOINC = {
|
|
129
|
+
"21401-5", # Mumps virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
|
|
130
|
+
"22416-2", # Mumps virus IgG Ab [Titer] in Cerebral spinal fluid
|
|
131
|
+
"22417-0", # Mumps virus IgG Ab [Titer] in Serum
|
|
132
|
+
"6477-4", # Mumps virus IgG Ab [Titer] in Serum by Immunofluorescence
|
|
133
|
+
}
|
|
134
|
+
|
|
135
|
+
|
|
136
|
+
class MumpsAntibodyTestIggAntibodyPresence(ValueSet):
|
|
137
|
+
"""
|
|
138
|
+
**Clinical Focus:** The purpose of this value set is to represent concepts for laboratory tests for the presence of mumps IgG antibody.
|
|
139
|
+
|
|
140
|
+
**Data Element Scope:** This value set may use a model element related to Laboratory Test.
|
|
141
|
+
|
|
142
|
+
**Inclusion Criteria:** Includes concepts that represent tests for the presence of mumps IgG in serum, cerebrospinal fluid or body fluid.
|
|
143
|
+
|
|
144
|
+
**Exclusion Criteria:** Excludes concepts that represent an order only.
|
|
145
|
+
|
|
146
|
+
** Used in:** CMS117v10
|
|
147
|
+
"""
|
|
148
|
+
|
|
149
|
+
VALUE_SET_NAME = "Mumps Antibody Test (IgG Antibody presence)"
|
|
150
|
+
OID = "2.16.840.1.113883.3.464.1003.198.12.1062"
|
|
151
|
+
DEFINITION_VERSION = "20170504"
|
|
152
|
+
EXPANSION_VERSION = "eCQM Update 2021-05-06"
|
|
153
|
+
|
|
154
|
+
LOINC = {
|
|
155
|
+
"22415-4", # Mumps virus IgG Ab [Presence] in Serum
|
|
156
|
+
"39011-2", # Mumps virus IgG Ab [Presence] in Cerebral spinal fluid
|
|
157
|
+
"40737-9", # Mumps virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
|
|
158
|
+
"6476-6", # Mumps virus IgG Ab [Presence] in Serum by Immunoassay
|
|
159
|
+
"74422-7", # Mumps virus IgG Ab [Presence] in Body fluid by Immunoassay
|
|
160
|
+
}
|
|
161
|
+
|
|
162
|
+
|
|
163
|
+
class RubellaAntibodyTestIggAntibodyTiter(ValueSet):
|
|
164
|
+
"""
|
|
165
|
+
**Clinical Focus:** The purpose of this value set is to represent concepts for laboratory tests for the titer of rubella IgG antibody.
|
|
166
|
+
|
|
167
|
+
**Data Element Scope:** This value set may use a model element related to Laboratory Test.
|
|
168
|
+
|
|
169
|
+
**Inclusion Criteria:** Includes concepts that represent tests for the rubella IgG titer in serum or cerebrospinal fluid.
|
|
170
|
+
|
|
171
|
+
**Exclusion Criteria:** Excludes concepts that represent an order only.
|
|
172
|
+
|
|
173
|
+
** Used in:** CMS117v10
|
|
174
|
+
"""
|
|
175
|
+
|
|
176
|
+
VALUE_SET_NAME = "Rubella Antibody Test (IgG Antibody Titer)"
|
|
177
|
+
OID = "2.16.840.1.113883.3.464.1003.198.12.1063"
|
|
178
|
+
DEFINITION_VERSION = "20170504"
|
|
179
|
+
EXPANSION_VERSION = "eCQM Update 2021-05-06"
|
|
180
|
+
|
|
181
|
+
LOINC = {
|
|
182
|
+
"41763-4", # Rubella virus IgG Ab [Titer] in Serum
|
|
183
|
+
"46110-3", # Rubella virus IgG Ab [Titer] in Cerebral spinal fluid
|
|
184
|
+
}
|
|
185
|
+
|
|
186
|
+
|
|
187
|
+
class RubellaAntibodyTestIggAntibodyPresence(ValueSet):
|
|
188
|
+
"""
|
|
189
|
+
**Clinical Focus:** The purpose of this value set is to represent concepts for laboratory tests for the presence of rubella IgG antibody.
|
|
190
|
+
|
|
191
|
+
**Data Element Scope:** This value set may use a model element related to Laboratory Test.
|
|
192
|
+
|
|
193
|
+
**Inclusion Criteria:** Includes concepts that represent tests for the presence of rubella IgG in serum, cerebrospinal fluid, body fluid.
|
|
194
|
+
|
|
195
|
+
**Exclusion Criteria:** Excludes concepts that represent an order only.
|
|
196
|
+
|
|
197
|
+
** Used in:** CMS117v10
|
|
198
|
+
"""
|
|
199
|
+
|
|
200
|
+
VALUE_SET_NAME = "Rubella Antibody Test (IgG Antibody presence)"
|
|
201
|
+
OID = "2.16.840.1.113883.3.464.1003.198.12.1064"
|
|
202
|
+
DEFINITION_VERSION = "20170504"
|
|
203
|
+
EXPANSION_VERSION = "eCQM Update 2021-05-06"
|
|
204
|
+
|
|
205
|
+
LOINC = {
|
|
206
|
+
"25514-1", # Rubella virus IgG Ab [Presence] in Serum
|
|
207
|
+
"39013-8", # Rubella virus IgG Ab [Presence] in Cerebral spinal fluid
|
|
208
|
+
"40667-8", # Rubella virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
|
|
209
|
+
"40668-6", # Rubella virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
|
|
210
|
+
"63462-6", # Rubella virus IgG Ab [Presence] in Serum by Latex agglutination
|
|
211
|
+
"74415-1", # Rubella virus IgG Ab [Presence] in Body fluid by Immunoassay
|
|
212
|
+
}
|
|
213
|
+
|
|
214
|
+
|
|
215
|
+
class VaricellaZosterAntibodyTestIggAntibodyPresence(ValueSet):
|
|
216
|
+
"""
|
|
217
|
+
**Clinical Focus:** The purpose of this value set is to represent concepts for laboratory tests for the presence of varicella zoster IgG antibody.
|
|
218
|
+
|
|
219
|
+
**Data Element Scope:** This value set may use a model element related to Laboratory Test.
|
|
220
|
+
|
|
221
|
+
**Inclusion Criteria:** Includes concepts that represent tests for the presence of varicella zoster IgG in serum, cerebrospinal fluid or body fluid.
|
|
222
|
+
|
|
223
|
+
**Exclusion Criteria:** Excludes concepts that represent an order only.
|
|
224
|
+
|
|
225
|
+
** Used in:** CMS117v10
|
|
226
|
+
"""
|
|
227
|
+
|
|
228
|
+
VALUE_SET_NAME = "Varicella Zoster Antibody Test (IgG Antibody Presence)"
|
|
229
|
+
OID = "2.16.840.1.113883.3.464.1003.198.12.1067"
|
|
230
|
+
DEFINITION_VERSION = "20170504"
|
|
231
|
+
EXPANSION_VERSION = "eCQM Update 2021-05-06"
|
|
232
|
+
|
|
233
|
+
LOINC = {
|
|
234
|
+
"15410-4", # Varicella zoster virus IgG Ab [Presence] in Serum by Immunoassay
|
|
235
|
+
"19162-7", # Varicella zoster virus IgG Ab [Presence] in Serum
|
|
236
|
+
"41512-5", # Varicella zoster virus IgG Ab [Presence] in Serum by Immunofluorescence
|
|
237
|
+
"42537-1", # Varicella zoster virus IgG Ab [Presence] in Cerebral spinal fluid
|
|
238
|
+
"53534-4", # Varicella zoster virus IgG Ab [Presence] in Body fluid by Immunoassay
|
|
239
|
+
}
|
|
240
|
+
|
|
241
|
+
|
|
242
|
+
class VaricellaZosterAntibodyTestIggAntibodyTiter(ValueSet):
|
|
243
|
+
"""
|
|
244
|
+
**Clinical Focus:** The purpose of this value set is to represent concepts for laboratory tests for the titer of varicella zoster IgG antibody.
|
|
245
|
+
|
|
246
|
+
**Data Element Scope:** This value set may use a model element related to Laboratory Test.
|
|
247
|
+
|
|
248
|
+
**Inclusion Criteria:** Includes concepts that represent tests for the varicella zoster IgG titer in serum or cerebrospinal fluid.
|
|
249
|
+
|
|
250
|
+
**Exclusion Criteria:** Excludes concepts that represent an order only.
|
|
251
|
+
|
|
252
|
+
** Used in:** CMS117v10
|
|
253
|
+
"""
|
|
254
|
+
|
|
255
|
+
VALUE_SET_NAME = "Varicella Zoster Antibody Test (IgG Antibody Titer)"
|
|
256
|
+
OID = "2.16.840.1.113883.3.464.1003.198.12.1066"
|
|
257
|
+
DEFINITION_VERSION = "20170504"
|
|
258
|
+
EXPANSION_VERSION = "eCQM Update 2021-05-06"
|
|
259
|
+
|
|
260
|
+
LOINC = {
|
|
261
|
+
"21595-4", # Varicella zoster virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence
|
|
262
|
+
"22601-9", # Varicella zoster virus IgG Ab [Titer] in Cerebral spinal fluid
|
|
263
|
+
"22602-7", # Varicella zoster virus IgG Ab [Titer] in Serum
|
|
264
|
+
"6569-8", # Varicella zoster virus IgG Ab [Titer] in Serum by Immunofluorescence
|
|
265
|
+
}
|
|
266
|
+
|
|
267
|
+
|
|
268
|
+
class Hba1CLaboratoryTest(ValueSet):
|
|
269
|
+
"""
|
|
270
|
+
**Clinical Focus:** The purpose of this value set is to represent concepts for hemoglobin A1c tests.
|
|
271
|
+
|
|
272
|
+
**Data Element Scope:** This value set may use a model element related to Laboratory Test.
|
|
273
|
+
|
|
274
|
+
**Inclusion Criteria:** Includes concepts that represent tests for hemoglobin A1c.
|
|
275
|
+
|
|
276
|
+
**Exclusion Criteria:** Excludes concepts that represent hemoglobin A1c laboratory tests that use the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) protocol and Japanese Diabetes Society (JDS)/Japanese Society of Clinical Chemistry (JSCC) protocol and exclude concepts that represent an order only.
|
|
277
|
+
|
|
278
|
+
** Used in:** CMS122v10
|
|
279
|
+
"""
|
|
280
|
+
|
|
281
|
+
VALUE_SET_NAME = "HbA1c Laboratory Test"
|
|
282
|
+
OID = "2.16.840.1.113883.3.464.1003.198.12.1013"
|
|
283
|
+
DEFINITION_VERSION = "20170504"
|
|
284
|
+
EXPANSION_VERSION = "eCQM Update 2021-05-06"
|
|
285
|
+
|
|
286
|
+
LOINC = {
|
|
287
|
+
"17856-6", # Hemoglobin A1c/Hemoglobin.total in Blood by HPLC
|
|
288
|
+
"4548-4", # Hemoglobin A1c/Hemoglobin.total in Blood
|
|
289
|
+
"4549-2", # Hemoglobin A1c/Hemoglobin.total in Blood by Electrophoresis
|
|
290
|
+
}
|
|
291
|
+
|
|
292
|
+
|
|
293
|
+
class HpvTest(ValueSet):
|
|
294
|
+
"""
|
|
295
|
+
**Clinical Focus:** The purpose of this value set is to represent concepts for human papilloma viruses (HPV).
|
|
296
|
+
|
|
297
|
+
**Data Element Scope:** This value set may use a model element related to Laboratory Test.
|
|
298
|
+
|
|
299
|
+
**Inclusion Criteria:** Includes concepts that represent tests for high-risk HPV in cervical samples.
|
|
300
|
+
|
|
301
|
+
**Exclusion Criteria:** Excludes concepts that represent tests for high-risk HPV conducted on non-cervical samples and tests that are ordered only.
|
|
302
|
+
|
|
303
|
+
** Used in:** CMS124v10
|
|
304
|
+
"""
|
|
305
|
+
|
|
306
|
+
VALUE_SET_NAME = "HPV Test"
|
|
307
|
+
OID = "2.16.840.1.113883.3.464.1003.110.12.1059"
|
|
308
|
+
DEFINITION_VERSION = "20170504"
|
|
309
|
+
EXPANSION_VERSION = "eCQM Update 2021-05-06"
|
|
310
|
+
|
|
311
|
+
LOINC = {
|
|
312
|
+
"21440-3", # Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA [Presence] in Cervix by Probe
|
|
313
|
+
"30167-1", # Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification
|
|
314
|
+
"38372-9", # Human papilloma virus 6+11+16+18+31+33+35+39+42+43+44+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification
|
|
315
|
+
"59263-4", # Human papilloma virus 16 DNA [Presence] in Cervix by Probe with signal amplification
|
|
316
|
+
"59264-2", # Human papilloma virus 18 DNA [Presence] in Cervix by Probe with signal amplification
|
|
317
|
+
"59420-0", # Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by Probe with signal amplification
|
|
318
|
+
"69002-4", # Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
|
|
319
|
+
"71431-1", # Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detection
|
|
320
|
+
"75694-0", # Human papilloma virus 18+45 E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
|
|
321
|
+
"77379-6", # Human papilloma virus 16 and 18 and 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Interpretation] in Cervix
|
|
322
|
+
"77399-4", # Human papilloma virus 16 DNA [Presence] in Cervix by NAA with probe detection
|
|
323
|
+
"77400-0", # Human papilloma virus 18 DNA [Presence] in Cervix by NAA with probe detection
|
|
324
|
+
"82354-2", # Human papilloma virus 16 and 18+45 E6+E7 mRNA [Identifier] in Cervix by NAA with probe detection
|
|
325
|
+
"82456-5", # Human papilloma virus 16 E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
|
|
326
|
+
"82675-0", # Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detection
|
|
327
|
+
}
|
|
328
|
+
|
|
329
|
+
|
|
330
|
+
class PapTest(ValueSet):
|
|
331
|
+
"""
|
|
332
|
+
**Clinical Focus:** The purpose of this value set is to represent concepts for cervical cytology tests.
|
|
333
|
+
|
|
334
|
+
**Data Element Scope:** This value set may use a model element related to Laboratory Test.
|
|
335
|
+
|
|
336
|
+
**Inclusion Criteria:** Includes concepts that represent tests for cervical cytology.
|
|
337
|
+
|
|
338
|
+
**Exclusion Criteria:** Excludes concepts that represent tests for cervical cytology conducted on non-cervical or non-vaginal samples and tests that are ordered only.
|
|
339
|
+
|
|
340
|
+
** Used in:** CMS124v10, CMS153v10
|
|
341
|
+
"""
|
|
342
|
+
|
|
343
|
+
VALUE_SET_NAME = "Pap Test"
|
|
344
|
+
OID = "2.16.840.1.113883.3.464.1003.108.12.1017"
|
|
345
|
+
DEFINITION_VERSION = "20170504"
|
|
346
|
+
EXPANSION_VERSION = "eCQM Update 2021-05-06"
|
|
347
|
+
|
|
348
|
+
LOINC = {
|
|
349
|
+
"10524-7", # Microscopic observation [Identifier] in Cervix by Cyto stain
|
|
350
|
+
"18500-9", # Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
|
|
351
|
+
"19762-4", # General categories [Interpretation] of Cervical or vaginal smear or scraping by Cyto stain
|
|
352
|
+
"19764-0", # Statement of adequacy [Interpretation] of Cervical or vaginal smear or scraping by Cyto stain
|
|
353
|
+
"19765-7", # Microscopic observation [Identifier] in Cervical or vaginal smear or scraping by Cyto stain
|
|
354
|
+
"19766-5", # Microscopic observation [Identifier] in Cervical or vaginal smear or scraping by Cyto stain Narrative
|
|
355
|
+
"19774-9", # Cytology study comment Cervical or vaginal smear or scraping Cyto stain
|
|
356
|
+
"33717-0", # Cytology Cervical or vaginal smear or scraping study
|
|
357
|
+
"47527-7", # Cytology report of Cervical or vaginal smear or scraping Cyto stain.thin prep
|
|
358
|
+
"47528-5", # Cytology report of Cervical or vaginal smear or scraping Cyto stain
|
|
359
|
+
}
|
|
360
|
+
|
|
361
|
+
|
|
362
|
+
class ProstateSpecificAntigenTest(ValueSet):
|
|
363
|
+
"""
|
|
364
|
+
**Clinical Focus:** The purpose of this value set is to represent concepts for laboratory tests measuring the prostate specific antigen (PSA).
|
|
365
|
+
|
|
366
|
+
**Data Element Scope:** This value set may use a model element related to Laboratory Test.
|
|
367
|
+
|
|
368
|
+
**Inclusion Criteria:** Includes concepts that represent a laboratory test for a prostate specific antigen (PSA).
|
|
369
|
+
|
|
370
|
+
**Exclusion Criteria:** No exclusions.
|
|
371
|
+
|
|
372
|
+
** Used in:** CMS129v11
|
|
373
|
+
"""
|
|
374
|
+
|
|
375
|
+
VALUE_SET_NAME = "Prostate Specific Antigen Test"
|
|
376
|
+
OID = "2.16.840.1.113883.3.526.3.401"
|
|
377
|
+
DEFINITION_VERSION = "20170504"
|
|
378
|
+
EXPANSION_VERSION = "eCQM Update 2021-05-06"
|
|
379
|
+
|
|
380
|
+
LOINC = {
|
|
381
|
+
"10508-0", # Prostate specific Ag [Presence] in Tissue by Immune stain
|
|
382
|
+
"10886-0", # Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
|
|
383
|
+
"12841-3", # Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
|
|
384
|
+
"15323-9", # Prostate specific Ag/Prostate volume calculated from height, width and length
|
|
385
|
+
"15324-7", # Prostate specific Ag/Prostate volume calculated from planimetry
|
|
386
|
+
"15325-4", # Prostate specific Ag/Prostate volume calculated
|
|
387
|
+
"19195-7", # Prostate specific Ag [Units/volume] in Serum or Plasma
|
|
388
|
+
"19201-3", # Prostate Specific Ag Free [Units/volume] in Serum or Plasma
|
|
389
|
+
"2857-1", # Prostate specific Ag [Mass/volume] in Serum or Plasma
|
|
390
|
+
"33667-7", # Prostate specific Ag.protein bound [Mass/volume] in Serum or Plasma
|
|
391
|
+
"34611-4", # Prostate specific Ag [Mass/volume] in Urine
|
|
392
|
+
"35741-8", # Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL
|
|
393
|
+
}
|
|
394
|
+
|
|
395
|
+
|
|
396
|
+
class FitDna(ValueSet):
|
|
397
|
+
"""
|
|
398
|
+
**Clinical Focus:** The purpose of this value set is to represent concepts for fecal immunochemical (FIT) DNA tests.
|
|
399
|
+
|
|
400
|
+
**Data Element Scope:** This value set may use a model element related to Laboratory Test.
|
|
401
|
+
|
|
402
|
+
**Inclusion Criteria:** Includes concepts that represent fecal immunochemical (FIT) DNA tests.
|
|
403
|
+
|
|
404
|
+
**Exclusion Criteria:** Excludes concepts that represent an order only.
|
|
405
|
+
|
|
406
|
+
** Used in:** CMS130v10
|
|
407
|
+
"""
|
|
408
|
+
|
|
409
|
+
VALUE_SET_NAME = "FIT DNA"
|
|
410
|
+
OID = "2.16.840.1.113883.3.464.1003.108.12.1039"
|
|
411
|
+
DEFINITION_VERSION = "20171219"
|
|
412
|
+
EXPANSION_VERSION = "eCQM Update 2021-05-06"
|
|
413
|
+
|
|
414
|
+
LOINC = {
|
|
415
|
+
"77353-1", # Noninvasive colorectal cancer DNA and occult blood screening [Interpretation] in Stool Narrative
|
|
416
|
+
"77354-9", # Noninvasive colorectal cancer DNA and occult blood screening [Presence] in Stool
|
|
417
|
+
}
|
|
418
|
+
|
|
419
|
+
|
|
420
|
+
class FecalOccultBloodTestFobt(ValueSet):
|
|
421
|
+
"""
|
|
422
|
+
**Clinical Focus:** The purpose of this value set is to represent concepts for fecal occult blood tests.
|
|
423
|
+
|
|
424
|
+
**Data Element Scope:** This value set may use a model element related to Laboratory Test.
|
|
425
|
+
|
|
426
|
+
**Inclusion Criteria:** Includes concepts that represent tests for occult blood in stool.
|
|
427
|
+
|
|
428
|
+
**Exclusion Criteria:** Excludes concepts that represent an order only and test for occult blood in other body fluids.
|
|
429
|
+
|
|
430
|
+
** Used in:** CMS130v10
|
|
431
|
+
"""
|
|
432
|
+
|
|
433
|
+
VALUE_SET_NAME = "Fecal Occult Blood Test (FOBT)"
|
|
434
|
+
OID = "2.16.840.1.113883.3.464.1003.198.12.1011"
|
|
435
|
+
DEFINITION_VERSION = "20171219"
|
|
436
|
+
EXPANSION_VERSION = "eCQM Update 2021-05-06"
|
|
437
|
+
|
|
438
|
+
LOINC = {
|
|
439
|
+
"12503-9", # Hemoglobin.gastrointestinal [Presence] in Stool --4th specimen
|
|
440
|
+
"12504-7", # Hemoglobin.gastrointestinal [Presence] in Stool --5th specimen
|
|
441
|
+
"14563-1", # Hemoglobin.gastrointestinal [Presence] in Stool --1st specimen
|
|
442
|
+
"14564-9", # Hemoglobin.gastrointestinal [Presence] in Stool --2nd specimen
|
|
443
|
+
"14565-6", # Hemoglobin.gastrointestinal [Presence] in Stool --3rd specimen
|
|
444
|
+
"2335-8", # Hemoglobin.gastrointestinal [Presence] in Stool
|
|
445
|
+
"27396-1", # Hemoglobin.gastrointestinal [Mass/mass] in Stool
|
|
446
|
+
"27401-9", # Hemoglobin.gastrointestinal [Presence] in Stool --6th specimen
|
|
447
|
+
"27925-7", # Hemoglobin.gastrointestinal [Presence] in Stool --7th specimen
|
|
448
|
+
"27926-5", # Hemoglobin.gastrointestinal [Presence] in Stool --8th specimen
|
|
449
|
+
"29771-3", # Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay
|
|
450
|
+
"56490-6", # Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay --2nd specimen
|
|
451
|
+
"56491-4", # Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay --3rd specimen
|
|
452
|
+
"57905-2", # Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay --1st specimen
|
|
453
|
+
"58453-2", # Hemoglobin.gastrointestinal.lower [Mass/volume] in Stool by Immunoassay
|
|
454
|
+
"80372-6", # Hemoglobin.gastrointestinal [Presence] in Stool by Rapid immunoassay
|
|
455
|
+
}
|
|
456
|
+
|
|
457
|
+
|
|
458
|
+
class UrineProteinTests(ValueSet):
|
|
459
|
+
"""
|
|
460
|
+
**Clinical Focus:** The purpose of this value set is to represent concepts for tests that measure urine protein.
|
|
461
|
+
|
|
462
|
+
**Data Element Scope:** This value set may use a model element related to Laboratory Test.
|
|
463
|
+
|
|
464
|
+
**Inclusion Criteria:** Includes concepts that represent tests for protein in urine.
|
|
465
|
+
|
|
466
|
+
**Exclusion Criteria:** Excludes concepts that represent an order only.
|
|
467
|
+
|
|
468
|
+
** Used in:** CMS134v10
|
|
469
|
+
"""
|
|
470
|
+
|
|
471
|
+
VALUE_SET_NAME = "Urine Protein Tests"
|
|
472
|
+
OID = "2.16.840.1.113883.3.464.1003.109.12.1024"
|
|
473
|
+
DEFINITION_VERSION = "20170504"
|
|
474
|
+
EXPANSION_VERSION = "eCQM Update 2021-05-06"
|
|
475
|
+
|
|
476
|
+
LOINC = {
|
|
477
|
+
"11218-5", # Microalbumin [Mass/volume] in Urine by Test strip
|
|
478
|
+
"12842-1", # Protein [Mass/volume] in 12 hour Urine
|
|
479
|
+
"13705-9", # Albumin/Creatinine [Mass Ratio] in 24 hour Urine
|
|
480
|
+
"13801-6", # Protein/Creatinine [Mass Ratio] in 24 hour Urine
|
|
481
|
+
"13986-5", # Albumin/Protein.total in 24 hour Urine by Electrophoresis
|
|
482
|
+
"13992-3", # Albumin/Protein.total in Urine by Electrophoresis
|
|
483
|
+
"14956-7", # Microalbumin [Mass/time] in 24 hour Urine
|
|
484
|
+
"14957-5", # Microalbumin [Mass/volume] in Urine
|
|
485
|
+
"14958-3", # Microalbumin/Creatinine [Mass Ratio] in 24 hour Urine
|
|
486
|
+
"14959-1", # Microalbumin/Creatinine [Mass Ratio] in Urine
|
|
487
|
+
"1753-3", # Albumin [Presence] in Urine
|
|
488
|
+
"1754-1", # Albumin [Mass/volume] in Urine
|
|
489
|
+
"1755-8", # Albumin [Mass/time] in 24 hour Urine
|
|
490
|
+
"1757-4", # Albumin renal clearance in 24 hour Urine and Serum or Plasma
|
|
491
|
+
"17819-4", # Albumin/Protein.total by Electrophoresis in Urine collected for unspecified duration
|
|
492
|
+
"18373-1", # Protein [Mass/time] in 6 hour Urine
|
|
493
|
+
"20454-5", # Protein [Presence] in Urine by Test strip
|
|
494
|
+
"20621-9", # Albumin/Creatinine [Presence] in Urine by Test strip
|
|
495
|
+
"21059-1", # Albumin [Mass/volume] in 24 hour Urine
|
|
496
|
+
"21482-5", # Protein [Mass/volume] in 24 hour Urine
|
|
497
|
+
"26801-1", # Protein [Mass/time] in 12 hour Urine
|
|
498
|
+
"27298-9", # Protein [Units/volume] in Urine
|
|
499
|
+
"2887-8", # Protein [Presence] in Urine
|
|
500
|
+
"2888-6", # Protein [Mass/volume] in Urine
|
|
501
|
+
"2889-4", # Protein [Mass/time] in 24 hour Urine
|
|
502
|
+
"2890-2", # Protein/Creatinine [Mass Ratio] in Urine
|
|
503
|
+
"29946-1", # Albumin [Presence] in 24 hour Urine by Electrophoresis
|
|
504
|
+
"30000-4", # Microalbumin/Creatinine [Ratio] in Urine
|
|
505
|
+
"30001-2", # Microalbumin/Creatinine [Ratio] in Urine by Test strip
|
|
506
|
+
"30003-8", # Microalbumin [Mass/volume] in 24 hour Urine
|
|
507
|
+
"32209-9", # Protein [Presence] in 24 hour Urine by Test strip
|
|
508
|
+
"32294-1", # Albumin/Creatinine [Ratio] in Urine
|
|
509
|
+
"32551-4", # Protein [Mass] in Urine collected for unspecified duration
|
|
510
|
+
"34366-5", # Protein/Creatinine [Ratio] in Urine
|
|
511
|
+
"35663-4", # Protein [Mass/volume] in Urine collected for unspecified duration
|
|
512
|
+
"40486-3", # Protein/Creatinine [Ratio] in 24 hour Urine
|
|
513
|
+
"40662-9", # Protein [Mass/time] in 12 hour Urine --resting
|
|
514
|
+
"40663-7", # Protein [Mass/time] in 12 hour Urine --upright
|
|
515
|
+
"43605-5", # Microalbumin [Mass/volume] in 4 hour Urine
|
|
516
|
+
"43606-3", # Microalbumin [Mass/time] in 4 hour Urine
|
|
517
|
+
"43607-1", # Microalbumin [Mass/time] in 12 hour Urine
|
|
518
|
+
"44292-1", # Microalbumin/Creatinine [Mass Ratio] in 12 hour Urine
|
|
519
|
+
"47558-2", # Microalbumin/Protein.total in 24 hour Urine
|
|
520
|
+
"49002-9", # Albumin [Mass/time] in Urine collected for unspecified duration
|
|
521
|
+
"49023-5", # Microalbumin [Mass/time] in Urine collected for unspecified duration
|
|
522
|
+
"50209-6", # Albumin [Mass/time] in Urine collected for unspecified duration --supine
|
|
523
|
+
"50561-0", # Protein [Mass/volume] in Urine by Automated test strip
|
|
524
|
+
"50949-7", # Albumin [Presence] in Urine by Test strip
|
|
525
|
+
"51190-7", # Albumin [Mass/volume] in 24 hour Urine by Electrophoresis
|
|
526
|
+
"53121-0", # Protein [Mass/time] in 1 hour Urine
|
|
527
|
+
"53525-2", # Protein [Presence] in Urine by SSA method
|
|
528
|
+
"53530-2", # Microalbumin [Mass/volume] in 24 hour Urine by Detection limit <= 1.0 mg/L
|
|
529
|
+
"53531-0", # Microalbumin [Mass/volume] in Urine by Detection limit <= 1.0 mg/L
|
|
530
|
+
"53532-8", # Microalbumin [Mass/time] in 24 hour Urine by Detection limit <= 1.0 mg/L
|
|
531
|
+
"56553-1", # Microalbumin [Mass/time] in 8 hour Urine
|
|
532
|
+
"57369-1", # Microalbumin [Mass/volume] in 12 hour Urine
|
|
533
|
+
"57735-3", # Protein [Presence] in Urine by Automated test strip
|
|
534
|
+
"5804-0", # Protein [Mass/volume] in Urine by Test strip
|
|
535
|
+
"58448-2", # Microalbumin ug/min [Mass/time] in 24 hour Urine
|
|
536
|
+
"58992-9", # Protein [Mass/time] in 18 hour Urine
|
|
537
|
+
"59159-4", # Microalbumin/Creatinine [Ratio] in 24 hour Urine
|
|
538
|
+
"60678-0", # Protein/Creatinine [Mass Ratio] in 12 hour Urine
|
|
539
|
+
"63474-1", # Microalbumin [Mass/time] in 18 hour Urine
|
|
540
|
+
"6941-9", # Albumin [Mass/time] in 24 hour Urine by Electrophoresis
|
|
541
|
+
"6942-7", # Albumin [Mass/volume] in Urine by Electrophoresis
|
|
542
|
+
"76401-9", # Albumin/Creatinine [Ratio] in 24 hour Urine
|
|
543
|
+
"77253-3", # Microalbumin/Creatinine [Ratio] in Urine by Detection limit <= 1.0 mg/L
|
|
544
|
+
"77254-1", # Microalbumin/Creatinine [Ratio] in 24 hour Urine by Detection limit <= 1.0 mg/L
|
|
545
|
+
"77940-5", # Albumin [Mass/volume] by Electrophoresis in Urine collected for unspecified duration
|
|
546
|
+
"89998-9", # Albumin/Creatinine [Ratio] in Urine by Detection limit <= 3.0 mg/L
|
|
547
|
+
"89999-7", # Albumin [Mass/volume] in Urine by Detection limit <= 3.0 mg/L
|
|
548
|
+
"90000-1", # Albumin [Mass/time] in 24 hour Urine by Detection limit <= 3.0 mg/L
|
|
549
|
+
"9318-7", # Albumin/Creatinine [Mass Ratio] in Urine
|
|
550
|
+
"93746-6", # Protein catabolic rate based on 24 hour Urine [Calculated]
|
|
551
|
+
"95232-5", # Microalbumin [Presence] in Urine by Test strip
|
|
552
|
+
"95233-3", # Microalbumin/Creatinine [Presence] in Urine by Test strip
|
|
553
|
+
}
|
|
554
|
+
|
|
555
|
+
|
|
556
|
+
class GroupAStreptococcusTest(ValueSet):
|
|
557
|
+
"""
|
|
558
|
+
**Clinical Focus:** The purpose of this value set is to represent concepts for group A streptococcus tests.
|
|
559
|
+
|
|
560
|
+
**Data Element Scope:** This value set may use a model element related to Laboratory Test.
|
|
561
|
+
|
|
562
|
+
**Inclusion Criteria:** Includes concepts that represent tests to identify the presence of group A streptococcus.
|
|
563
|
+
|
|
564
|
+
**Exclusion Criteria:** Excludes concepts that represent an order only.
|
|
565
|
+
|
|
566
|
+
** Used in:** CMS146v10
|
|
567
|
+
"""
|
|
568
|
+
|
|
569
|
+
VALUE_SET_NAME = "Group A Streptococcus Test"
|
|
570
|
+
OID = "2.16.840.1.113883.3.464.1003.198.12.1012"
|
|
571
|
+
DEFINITION_VERSION = "20170504"
|
|
572
|
+
EXPANSION_VERSION = "eCQM Update 2021-05-06"
|
|
573
|
+
|
|
574
|
+
LOINC = {
|
|
575
|
+
"11268-0", # Streptococcus pyogenes [Presence] in Throat by Organism specific culture
|
|
576
|
+
"17656-0", # Streptococcus pyogenes [Presence] in Specimen by Organism specific culture
|
|
577
|
+
"17898-8", # Bacteria identified in Throat by Aerobe culture
|
|
578
|
+
"18481-2", # Streptococcus pyogenes Ag [Presence] in Throat
|
|
579
|
+
"31971-5", # Streptococcus pyogenes Ag [Presence] in Specimen
|
|
580
|
+
"49610-9", # Streptococcus pyogenes DNA [Identifier] in Specimen by NAA with probe detection
|
|
581
|
+
"5036-9", # Streptococcus pyogenes rRNA [Presence] in Specimen by Probe
|
|
582
|
+
"60489-2", # Streptococcus pyogenes DNA [Presence] in Throat by NAA with probe detection
|
|
583
|
+
"626-2", # Bacteria identified in Throat by Culture
|
|
584
|
+
"6557-3", # Streptococcus pyogenes Ag [Presence] in Throat by Immunofluorescence
|
|
585
|
+
"6558-1", # Streptococcus pyogenes Ag [Presence] in Specimen by Immunoassay
|
|
586
|
+
"6559-9", # Streptococcus pyogenes Ag [Presence] in Specimen by Immunofluorescence
|
|
587
|
+
"68954-7", # Streptococcus pyogenes rRNA [Presence] in Throat by Probe
|
|
588
|
+
"78012-2", # Streptococcus pyogenes Ag [Presence] in Throat by Rapid immunoassay
|
|
589
|
+
"96331-4", # Streptococcus pyogenes DNA [NCncRange] in Lower respiratory specimen Qualitative by NAA with non-probe detection
|
|
590
|
+
}
|
|
591
|
+
|
|
592
|
+
|
|
593
|
+
class ChlamydiaScreening(ValueSet):
|
|
594
|
+
"""
|
|
595
|
+
**Clinical Focus:** The purpose of this value set is to represent concepts for chlamydia tests.
|
|
596
|
+
|
|
597
|
+
**Data Element Scope:** This value set may use a model element related to Laboratory Test.
|
|
598
|
+
|
|
599
|
+
**Inclusion Criteria:** Includes concepts that represent screening for chlamydia infections.
|
|
600
|
+
|
|
601
|
+
**Exclusion Criteria:** Excludes concepts that represent an order only.
|
|
602
|
+
|
|
603
|
+
** Used in:** CMS153v10
|
|
604
|
+
"""
|
|
605
|
+
|
|
606
|
+
VALUE_SET_NAME = "Chlamydia Screening"
|
|
607
|
+
OID = "2.16.840.1.113883.3.464.1003.110.12.1052"
|
|
608
|
+
DEFINITION_VERSION = "20170504"
|
|
609
|
+
EXPANSION_VERSION = "eCQM Update 2021-05-06"
|
|
610
|
+
|
|
611
|
+
LOINC = {
|
|
612
|
+
"14463-4", # Chlamydia trachomatis [Presence] in Cervix by Organism specific culture
|
|
613
|
+
"14464-2", # Chlamydia trachomatis [Presence] in Vaginal fluid by Organism specific culture
|
|
614
|
+
"14467-5", # Chlamydia trachomatis [Presence] in Urine sediment by Organism specific culture
|
|
615
|
+
"14474-1", # Chlamydia trachomatis Ag [Presence] in Urine sediment by Immunoassay
|
|
616
|
+
"14513-6", # Chlamydia trachomatis Ag [Presence] in Urine sediment by Immunofluorescence
|
|
617
|
+
"16600-9", # Chlamydia trachomatis rRNA [Presence] in Genital specimen by Probe
|
|
618
|
+
"21190-4", # Chlamydia trachomatis DNA [Presence] in Cervix by NAA with probe detection
|
|
619
|
+
"21191-2", # Chlamydia trachomatis DNA [Presence] in Urethra by NAA with probe detection
|
|
620
|
+
"21613-5", # Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
|
|
621
|
+
"23838-6", # Chlamydia trachomatis rRNA [Presence] in Genital fluid by Probe
|
|
622
|
+
"31775-0", # Chlamydia trachomatis Ag [Presence] in Urine sediment
|
|
623
|
+
"31777-6", # Chlamydia trachomatis Ag [Presence] in Specimen
|
|
624
|
+
"36902-5", # Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
|
|
625
|
+
"36903-3", # Chlamydia trachomatis and Neisseria gonorrhoeae DNA [Identifier] in Specimen by NAA with probe detection
|
|
626
|
+
"42931-6", # Chlamydia trachomatis rRNA [Presence] in Urine by NAA with probe detection
|
|
627
|
+
"43304-5", # Chlamydia trachomatis rRNA [Presence] in Specimen by NAA with probe detection
|
|
628
|
+
"43404-3", # Chlamydia trachomatis DNA [Presence] in Specimen by Probe with signal amplification
|
|
629
|
+
"43405-0", # Chlamydia trachomatis and Neisseria gonorrhoeae DNA [Identifier] in Specimen by Probe with signal amplification
|
|
630
|
+
"43406-8", # Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Specimen by Probe with signal amplification
|
|
631
|
+
"44806-8", # Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
|
|
632
|
+
"44807-6", # Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Genital specimen by NAA with probe detection
|
|
633
|
+
"45068-4", # Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Cervix by NAA with probe detection
|
|
634
|
+
"45069-2", # Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Genital specimen by Probe
|
|
635
|
+
"45075-9", # Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Urethra by Probe
|
|
636
|
+
"45076-7", # Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Specimen by Probe
|
|
637
|
+
"45084-1", # Chlamydia trachomatis DNA [Presence] in Vaginal fluid by NAA with probe detection
|
|
638
|
+
"45091-6", # Chlamydia trachomatis Ag [Presence] in Genital specimen
|
|
639
|
+
"45095-7", # Chlamydia trachomatis [Presence] in Genital specimen by Organism specific culture
|
|
640
|
+
"45098-1", # Chlamydia sp identified in Cervix by Organism specific culture
|
|
641
|
+
"45100-5", # Chlamydia sp identified in Vaginal fluid by Organism specific culture
|
|
642
|
+
"47211-8", # Chlamydia trachomatis L2 DNA [Presence] in Specimen by NAA with probe detection
|
|
643
|
+
"47212-6", # Chlamydia trachomatis DNA [Identifier] in Specimen by NAA with probe detection
|
|
644
|
+
"49096-1", # Chlamydia trachomatis DNA [Units/volume] in Specimen by NAA with probe detection
|
|
645
|
+
"4993-2", # Chlamydia trachomatis rRNA [Presence] in Specimen by Probe
|
|
646
|
+
"50387-0", # Chlamydia trachomatis rRNA [Presence] in Cervix by NAA with probe detection
|
|
647
|
+
"53925-4", # Chlamydia trachomatis rRNA [Presence] in Urethra by NAA with probe detection
|
|
648
|
+
"53926-2", # Chlamydia trachomatis rRNA [Presence] in Vaginal fluid by NAA with probe detection
|
|
649
|
+
"557-9", # Chlamydia sp identified in Genital specimen by Organism specific culture
|
|
650
|
+
"560-3", # Chlamydia sp identified in Specimen by Organism specific culture
|
|
651
|
+
"6349-5", # Chlamydia trachomatis [Presence] in Specimen by Organism specific culture
|
|
652
|
+
"6354-5", # Chlamydia trachomatis Ag [Presence] in Specimen by Immunoassay
|
|
653
|
+
"6355-2", # Chlamydia trachomatis Ag [Presence] in Specimen by Immunofluorescence
|
|
654
|
+
"6356-0", # Chlamydia trachomatis DNA [Presence] in Genital specimen by NAA with probe detection
|
|
655
|
+
"6357-8", # Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
|
|
656
|
+
"80360-1", # Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Urine by NAA with probe detection
|
|
657
|
+
"80361-9", # Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Cervix by NAA with probe detection
|
|
658
|
+
"80362-7", # Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Vaginal fluid by NAA with probe detection
|
|
659
|
+
"91860-7", # Chlamydia trachomatis Ag [Presence] in Genital specimen by Immunofluorescence
|
|
660
|
+
}
|
|
661
|
+
|
|
662
|
+
|
|
663
|
+
class LabTestsDuringPregnancy(ValueSet):
|
|
664
|
+
"""
|
|
665
|
+
**Clinical Focus:** The purpose of this value set is to represent concepts for laboratory tests conducted during pregnancy.
|
|
666
|
+
|
|
667
|
+
**Data Element Scope:** This value set may use a model element related to Laboratory Test.
|
|
668
|
+
|
|
669
|
+
**Inclusion Criteria:** Includes concepts that represent tests conducted during pregnancy.
|
|
670
|
+
|
|
671
|
+
**Exclusion Criteria:** Excludes concepts that represent an order only.
|
|
672
|
+
|
|
673
|
+
** Used in:** CMS153v10
|
|
674
|
+
"""
|
|
675
|
+
|
|
676
|
+
VALUE_SET_NAME = "Lab Tests During Pregnancy"
|
|
677
|
+
OID = "2.16.840.1.113883.3.464.1003.111.12.1007"
|
|
678
|
+
DEFINITION_VERSION = "20170504"
|
|
679
|
+
EXPANSION_VERSION = "eCQM Update 2021-05-06"
|
|
680
|
+
|
|
681
|
+
LOINC = {
|
|
682
|
+
"15019-3", # Alpha-1-Fetoprotein [Moles/volume] in Amniotic fluid
|
|
683
|
+
"1832-5", # Alpha-1-Fetoprotein [Mass/volume] in Amniotic fluid
|
|
684
|
+
"1834-1", # Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
|
|
685
|
+
"19171-8", # Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
|
|
686
|
+
"19176-7", # Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
|
|
687
|
+
"19177-5", # Alpha-1-Fetoprotein [Moles/volume] in Serum or Plasma
|
|
688
|
+
"20403-2", # Fibronectin.fetal [Mass/volume] in Vaginal fluid
|
|
689
|
+
"20404-0", # Fibronectin.fetal [Presence] in Vaginal fluid
|
|
690
|
+
"31993-9", # Alpha-1-Fetoprotein [Presence] in Serum or Plasma
|
|
691
|
+
"34493-7", # PRF1 gene targeted mutation analysis in Amniotic fluid by Molecular genetics method
|
|
692
|
+
"35457-1", # Maternal cell contamination [Identifier] in Amniotic fluid Nominal
|
|
693
|
+
"41067-0", # PRF1 gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal
|
|
694
|
+
"41096-9", # KEL gene allele [Genotype] in Amniotic fluid by Molecular genetics method Nominal
|
|
695
|
+
"41273-4", # Alpha-1-Fetoprotein interpretation in Amniotic fluid
|
|
696
|
+
"41274-2", # Alpha-1-Fetoprotein interpretation in Serum or Plasma
|
|
697
|
+
"43798-8", # Alpha-1-Fetoprotein [Presence] in Amniotic fluid
|
|
698
|
+
"46989-0", # CFTR gene targeted mutation analysis in Amniotic fluid by Molecular genetics method
|
|
699
|
+
"48039-2", # Fibronectin.fetal [Presence] in Specimen
|
|
700
|
+
"48781-9", # CYP21A2 gene mutations found [Identifier] in Amniotic fluid by Molecular genetics method Nominal
|
|
701
|
+
"48802-3", # Alpha-1-Fetoprotein panel - Serum or Plasma
|
|
702
|
+
"49246-2", # Alpha-1-Fetoprotein interpretation in Serum or Plasma Narrative
|
|
703
|
+
"49318-9", # Alpha-1-Fetoprotein interpretation in Amniotic fluid Narrative
|
|
704
|
+
"83072-9", # Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma by Immunoassay
|
|
705
|
+
"83073-7", # Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma by Immunoassay
|
|
706
|
+
"83075-2", # Alpha-1-Fetoprotein [Mass/volume] in Amniotic fluid by Immunoassay
|
|
707
|
+
}
|
|
708
|
+
|
|
709
|
+
|
|
710
|
+
class LabTestsForSexuallyTransmittedInfections(ValueSet):
|
|
711
|
+
"""
|
|
712
|
+
**Clinical Focus:** The purpose of this value set is to represent concepts for laboratory tests for sexually transmitted infections.
|
|
713
|
+
|
|
714
|
+
**Data Element Scope:** This value set may use a model element related to Laboratory Test.
|
|
715
|
+
|
|
716
|
+
**Inclusion Criteria:** Includes concepts that represent tests for sexually transmitted infections.
|
|
717
|
+
|
|
718
|
+
**Exclusion Criteria:** Excludes concepts that represent an order only.
|
|
719
|
+
|
|
720
|
+
** Used in:** CMS153v10
|
|
721
|
+
"""
|
|
722
|
+
|
|
723
|
+
VALUE_SET_NAME = "Lab Tests for Sexually Transmitted Infections"
|
|
724
|
+
OID = "2.16.840.1.113883.3.464.1003.110.12.1051"
|
|
725
|
+
DEFINITION_VERSION = "20170504"
|
|
726
|
+
EXPANSION_VERSION = "eCQM Update 2021-05-06"
|
|
727
|
+
|
|
728
|
+
LOINC = {
|
|
729
|
+
"10705-2", # Human papilloma virus Ag [Presence] in Tissue by Immune stain
|
|
730
|
+
"11083-3", # Human papilloma virus identified in Cervix
|
|
731
|
+
"11084-1", # Reagin Ab [Titer] in Serum
|
|
732
|
+
"11481-9", # Human papilloma virus identified in Specimen
|
|
733
|
+
"11597-2", # Treponema pallidum Ab [Units/volume] in Serum
|
|
734
|
+
"12222-6", # Human papilloma virus Ag [Presence] in Genital specimen
|
|
735
|
+
"12223-4", # Human papilloma virus 16+18 Ag [Presence] in Genital specimen
|
|
736
|
+
"13288-6", # Treponema pallidum Ab [Units/volume] in Blood by Immunofluorescence
|
|
737
|
+
"13321-5", # Human papilloma virus IgG Ab [Presence] in Serum
|
|
738
|
+
"13322-3", # Human papilloma virus IgM Ab [Presence] in Serum
|
|
739
|
+
"14499-8", # Human papilloma virus Ag [Presence] in Cervix
|
|
740
|
+
"14500-3", # Human papilloma virus Ag [Presence] in Vaginal fluid
|
|
741
|
+
"14502-9", # Human papilloma virus Ag [Presence] in Urethra
|
|
742
|
+
"14503-7", # Human papilloma virus 16+18 Ag [Presence] in Cervix
|
|
743
|
+
"14504-5", # Human papilloma virus 16+18 Ag [Presence] in Vaginal fluid
|
|
744
|
+
"14506-0", # Human papilloma virus 16+18 Ag [Presence] in Urethra
|
|
745
|
+
"16280-0", # Human papilloma virus DNA [Presence] in Specimen by Probe with amplification
|
|
746
|
+
"17398-9", # Human papilloma virus 11 Ag [Presence] in Specimen
|
|
747
|
+
"17399-7", # Human papilloma virus 16 Ag [Presence] in Specimen
|
|
748
|
+
"17400-3", # Human papilloma virus 16+18 Ag [Presence] in Specimen
|
|
749
|
+
"17401-1", # Human papilloma virus 18 Ag [Presence] in Specimen
|
|
750
|
+
"17402-9", # Human papilloma virus 31 Ag [Presence] in Specimen
|
|
751
|
+
"17403-7", # Human papilloma virus 31+33+35 Ag [Presence] in Specimen
|
|
752
|
+
"17404-5", # Human papilloma virus 33 Ag [Presence] in Specimen
|
|
753
|
+
"17405-2", # Human papilloma virus 42 Ag [Presence] in Specimen
|
|
754
|
+
"17406-0", # Human papilloma virus 43 Ag [Presence] in Specimen
|
|
755
|
+
"17407-8", # Human papilloma virus 44 Ag [Presence] in Specimen
|
|
756
|
+
"17408-6", # Human papilloma virus 45 Ag [Presence] in Specimen
|
|
757
|
+
"17409-4", # Human papilloma virus 5 Ag [Presence] in Specimen
|
|
758
|
+
"17410-2", # Human papilloma virus 51 Ag [Presence] in Specimen
|
|
759
|
+
"17411-0", # Human papilloma virus 6 Ag [Presence] in Specimen
|
|
760
|
+
"17412-8", # Human papilloma virus 6+11 Ag [Presence] in Specimen
|
|
761
|
+
"17723-8", # Treponema pallidum Ab [Presence] in Serum by Immobilization
|
|
762
|
+
"17724-6", # Treponema pallidum Ab [Units/volume] in Serum by Immunofluorescence
|
|
763
|
+
"17725-3", # Treponema pallidum Ab [Units/volume] in Serum by Latex agglutination
|
|
764
|
+
"17726-1", # Treponema pallidum IgG Ab [Presence] in Serum by Immunofluorescence
|
|
765
|
+
"17727-9", # Treponema pallidum IgG Ab [Units/volume] in Serum by Immunofluorescence
|
|
766
|
+
"17728-7", # Treponema pallidum IgM Ab [Units/volume] in Serum by Immunofluorescence
|
|
767
|
+
"17729-5", # Treponema pallidum IgM Ab [Presence] in Serum by Immunofluorescence
|
|
768
|
+
"18478-8", # Human papilloma virus 16+18 DNA [Presence] in Tissue by Probe
|
|
769
|
+
"18479-6", # Human papilloma virus 31+35+51 DNA [Presence] in Tissue by Probe
|
|
770
|
+
"18480-4", # Human papilloma virus 6+11 DNA [Presence] in Tissue by Probe
|
|
771
|
+
"20507-0", # Reagin Ab [Presence] in Serum by RPR
|
|
772
|
+
"20508-8", # Reagin Ab [Units/volume] in Serum by RPR
|
|
773
|
+
"21414-8", # Neisseria gonorrhoeae DNA [Presence] in Cervical mucus by NAA with probe detection
|
|
774
|
+
"21415-5", # Neisseria gonorrhoeae DNA [Presence] in Urethra by NAA with probe detection
|
|
775
|
+
"21440-3", # Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA [Presence] in Cervix by Probe
|
|
776
|
+
"21441-1", # Human papilloma virus 6+11+42+43+44 DNA [Presence] in Cervix by Probe
|
|
777
|
+
"22430-3", # Neisseria gonorrhoeae Ab [Titer] in Serum
|
|
778
|
+
"22434-5", # Human papilloma virus Ab [Presence] in Tissue
|
|
779
|
+
"22461-8", # Reagin Ab [Presence] in Serum
|
|
780
|
+
"22462-6", # Reagin Ab [Units/volume] in Serum
|
|
781
|
+
"22585-4", # Treponema pallidum Ab [Units/volume] in Blood
|
|
782
|
+
"22587-0", # Treponema pallidum Ab [Presence] in Serum
|
|
783
|
+
"22590-4", # Treponema pallidum Ab [Titer] in Serum
|
|
784
|
+
"22592-0", # Treponema pallidum IgG Ab [Units/volume] in Serum
|
|
785
|
+
"22594-6", # Treponema pallidum IgM Ab [Units/volume] in Serum
|
|
786
|
+
"24110-9", # Treponema pallidum Ab [Presence] in Serum by Immunoassay
|
|
787
|
+
"24111-7", # Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
|
|
788
|
+
"24312-1", # Treponema pallidum Ab [Presence] in Serum by Agglutination
|
|
789
|
+
"26009-1", # Treponema pallidum Ab [Titer] in Serum by Hemagglutination
|
|
790
|
+
"29311-8", # Neisseria gonorrhoeae Ag [Presence] in Specimen by Immunofluorescence
|
|
791
|
+
"30167-1", # Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification
|
|
792
|
+
"31147-2", # Reagin Ab [Titer] in Serum by RPR
|
|
793
|
+
"31905-3", # Neisseria gonorrhoeae Ag [Presence] in Genital specimen
|
|
794
|
+
"31906-1", # Neisseria gonorrhoeae Ag [Presence] in Specimen
|
|
795
|
+
"32047-3", # Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+68+70 DNA [Presence] in Tissue by Probe
|
|
796
|
+
"32198-4", # Neisseria gonorrhoeae rRNA [Presence] in Cervix by Probe
|
|
797
|
+
"32199-2", # Neisseria gonorrhoeae rRNA [Presence] in Urethra by Probe
|
|
798
|
+
"32704-9", # Neisseria gonorrhoeae Ab [Presence] in Serum
|
|
799
|
+
"32705-6", # Neisseria gonorrhoeae DNA [Presence] in Vaginal fluid by NAA with probe detection
|
|
800
|
+
"34147-9", # Treponema pallidum IgG+IgM Ab [Presence] in Serum
|
|
801
|
+
"34382-2", # Treponema pallidum Ab [Titer] in Serum by Immunofluorescence
|
|
802
|
+
"38372-9", # Human papilloma virus 6+11+16+18+31+33+35+39+42+43+44+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification
|
|
803
|
+
"40679-3", # Treponema pallidum IgG Ab [Presence] in Serum by Immunoblot
|
|
804
|
+
"40680-1", # Treponema pallidum IgM Ab [Presence] in Serum by Immunoblot
|
|
805
|
+
"41122-3", # Treponema pallidum Ab [Units/volume] in Specimen
|
|
806
|
+
"42481-2", # Human papilloma virus 6+11+42+43+44 DNA [Presence] in Cervix by Probe with signal amplification
|
|
807
|
+
"43170-0", # Human papilloma virus 31+33 DNA [Presence] in Tissue by Probe with signal amplification
|
|
808
|
+
"43305-2", # Neisseria gonorrhoeae rRNA [Presence] in Specimen by NAA with probe detection
|
|
809
|
+
"43403-5", # Neisseria gonorrhoeae DNA [Presence] in Specimen by Probe with signal amplification
|
|
810
|
+
"44543-7", # Human papilloma virus 31+33 Ag [Presence] in Specimen
|
|
811
|
+
"44544-5", # Human papilloma virus 35 Ag [Presence] in Specimen
|
|
812
|
+
"44545-2", # Human papilloma virus DNA [Presence] in Urethra by Probe
|
|
813
|
+
"44546-0", # Human papilloma virus DNA [Presence] in Vaginal fluid by Probe
|
|
814
|
+
"44547-8", # Human papilloma virus DNA [Presence] in Specimen by Probe with signal amplification
|
|
815
|
+
"44548-6", # Human papilloma virus DNA [Presence] in Urethra by Probe with signal amplification
|
|
816
|
+
"44549-4", # Human papilloma virus DNA [Presence] in Vaginal fluid by Probe with signal amplification
|
|
817
|
+
"44550-2", # Human papilloma virus DNA [Presence] in Cervix by Probe
|
|
818
|
+
"44551-0", # Human papilloma virus DNA [Presence] in Tissue by Probe
|
|
819
|
+
"47236-5", # Treponema pallidum IgG+IgM Ab [Presence] in Serum by Immunoassay
|
|
820
|
+
"47237-3", # Treponema pallidum IgM Ab [Presence] in Serum by Immunoassay
|
|
821
|
+
"47238-1", # Treponema pallidum IgG Ab [Presence] in Serum by Immunoassay
|
|
822
|
+
"47387-6", # Neisseria gonorrhoeae DNA [Presence] in Genital specimen by NAA with probe detection
|
|
823
|
+
"48560-7", # Human papilloma virus genotype [Identifier] in Specimen by NAA with probe detection
|
|
824
|
+
"49891-5", # Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
|
|
825
|
+
"49896-4", # Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Specimen by NAA with probe detection
|
|
826
|
+
"5028-6", # Neisseria gonorrhoeae rRNA [Presence] in Specimen by Probe
|
|
827
|
+
"50326-8", # Neisseria gonorrhoeae DNA [Presence] in Specimen from Donor by NAA with probe detection
|
|
828
|
+
"50388-8", # Neisseria gonorrhoeae rRNA [Presence] in Cervix by NAA with probe detection
|
|
829
|
+
"50412-6", # Neisseria gonorrhoeae rRNA [Presence] in Specimen from Donor by NAA with probe detection
|
|
830
|
+
"50690-7", # Reagin Ab [Titer] in Serum by VDRL
|
|
831
|
+
"51838-1", # Treponema pallidum IgG Ab [Units/volume] in Serum by Immunoassay
|
|
832
|
+
"51839-9", # Treponema pallidum IgM Ab [Units/volume] in Serum by Immunoassay
|
|
833
|
+
"5291-0", # Reagin Ab [Units/volume] in Serum by VDRL
|
|
834
|
+
"5292-8", # Reagin Ab [Presence] in Serum by VDRL
|
|
835
|
+
"53762-1", # Neisseria gonorrhoeae IgG Ab [Titer] in Serum
|
|
836
|
+
"53879-3", # Neisseria gonorrhoeae rRNA [Presence] in Vaginal fluid by NAA with probe detection
|
|
837
|
+
"5392-6", # Treponema pallidum Ab [Units/volume] in Serum by Immobilization
|
|
838
|
+
"53927-0", # Neisseria gonorrhoeae rRNA [Presence] in Urethra by NAA with probe detection
|
|
839
|
+
"5393-4", # Treponema pallidum Ab [Presence] in Serum by Immunofluorescence
|
|
840
|
+
"5394-2", # Treponema pallidum Ab [Titer] in Serum by Latex agglutination
|
|
841
|
+
"55298-4", # Human papilloma virus 6+11+42+43+44 DNA [Presence] in Urethra by Probe with signal amplification
|
|
842
|
+
"55299-2", # Human papilloma virus 6+11+42+43+44 DNA [Presence] in Specimen by Probe with signal amplification
|
|
843
|
+
"57032-5", # Treponema pallidum Ab [Presence] in Serum by Immunoblot
|
|
844
|
+
"59263-4", # Human papilloma virus 16 DNA [Presence] in Cervix by Probe with signal amplification
|
|
845
|
+
"59264-2", # Human papilloma virus 18 DNA [Presence] in Cervix by Probe with signal amplification
|
|
846
|
+
"59420-0", # Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by Probe with signal amplification
|
|
847
|
+
"61372-9", # Human papilloma virus 16 DNA [Presence] in Specimen by NAA with probe detection
|
|
848
|
+
"61373-7", # Human papilloma virus 18 DNA [Presence] in Specimen by NAA with probe detection
|
|
849
|
+
"61374-5", # Human papilloma virus 26 DNA [Presence] in Specimen by NAA with probe detection
|
|
850
|
+
"61375-2", # Human papilloma virus 31 DNA [Presence] in Specimen by NAA with probe detection
|
|
851
|
+
"61376-0", # Human papilloma virus 33 DNA [Presence] in Specimen by NAA with probe detection
|
|
852
|
+
"61377-8", # Human papilloma virus 35 DNA [Presence] in Specimen by NAA with probe detection
|
|
853
|
+
"61378-6", # Human papilloma virus 39 DNA [Presence] in Specimen by NAA with probe detection
|
|
854
|
+
"61379-4", # Human papilloma virus 44 DNA [Presence] in Specimen by NAA with probe detection
|
|
855
|
+
"61380-2", # Human papilloma virus 45 DNA [Presence] in Specimen by NAA with probe detection
|
|
856
|
+
"61381-0", # Human papilloma virus 51 DNA [Presence] in Specimen by NAA with probe detection
|
|
857
|
+
"61382-8", # Human papilloma virus 52 DNA [Presence] in Specimen by NAA with probe detection
|
|
858
|
+
"61383-6", # Human papilloma virus 53 DNA [Presence] in Specimen by NAA with probe detection
|
|
859
|
+
"61384-4", # Human papilloma virus 58 DNA [Presence] in Specimen by NAA with probe detection
|
|
860
|
+
"61385-1", # Human papilloma virus 59 DNA [Presence] in Specimen by NAA with probe detection
|
|
861
|
+
"61386-9", # Human papilloma virus 66 DNA [Presence] in Specimen by NAA with probe detection
|
|
862
|
+
"61387-7", # Human papilloma virus 67 DNA [Presence] in Specimen by NAA with probe detection
|
|
863
|
+
"61388-5", # Human papilloma virus 68 DNA [Presence] in Specimen by NAA with probe detection
|
|
864
|
+
"61389-3", # Human papilloma virus 69 DNA [Presence] in Specimen by NAA with probe detection
|
|
865
|
+
"61390-1", # Human papilloma virus 70 DNA [Presence] in Specimen by NAA with probe detection
|
|
866
|
+
"61391-9", # Human papilloma virus 73 DNA [Presence] in Specimen by NAA with probe detection
|
|
867
|
+
"61392-7", # Human papilloma virus 82 DNA [Presence] in Specimen by NAA with probe detection
|
|
868
|
+
"61393-5", # Human papilloma virus 6 DNA [Presence] in Specimen by NAA with probe detection
|
|
869
|
+
"61394-3", # Human papilloma virus 11 DNA [Presence] in Specimen by NAA with probe detection
|
|
870
|
+
"61395-0", # Human papilloma virus 42 DNA [Presence] in Specimen by NAA with probe detection
|
|
871
|
+
"61396-8", # Human papilloma virus 56 DNA [Presence] in Specimen by NAA with probe detection
|
|
872
|
+
"63464-2", # Treponema pallidum Ab [Units/volume] in Serum by Immunoassay
|
|
873
|
+
"6487-3", # Neisseria gonorrhoeae Ag [Presence] in Genital specimen by Immunoassay
|
|
874
|
+
"6488-1", # Neisseria gonorrhoeae Ag [Presence] in Genital specimen by Immunofluorescence
|
|
875
|
+
"6489-9", # Neisseria gonorrhoeae Ag [Presence] in Genital specimen by Latex agglutination
|
|
876
|
+
"6490-7", # Neisseria gonorrhoeae Ag [Presence] in Urethra
|
|
877
|
+
"6510-2", # Human papilloma virus Ab [Presence] in Genital specimen by Immunoassay
|
|
878
|
+
"6511-0", # Human papilloma virus Ab [Presence] in Genital specimen by Immunoblot
|
|
879
|
+
"6512-8", # Human papilloma virus Ab [Presence] in Tissue by Immunoassay
|
|
880
|
+
"6513-6", # Human papilloma virus Ab [Presence] in Tissue by Immunoblot
|
|
881
|
+
"6514-4", # Human papilloma virus rRNA [Presence] in Genital specimen by NAA with probe detection
|
|
882
|
+
"6515-1", # Human papilloma virus rRNA [Presence] in Tissue by NAA with probe detection
|
|
883
|
+
"6516-9", # Human papilloma virus rRNA [Presence] in Specimen by NAA with probe detection
|
|
884
|
+
"6561-5", # Treponema pallidum IgG Ab [Presence] in Serum
|
|
885
|
+
"6562-3", # Treponema pallidum IgM Ab [Presence] in Serum
|
|
886
|
+
"688-2", # Neisseria gonorrhoeae [Presence] in Cervix by Organism specific culture
|
|
887
|
+
"690-8", # Neisseria gonorrhoeae [Presence] in Endometrium by Organism specific culture
|
|
888
|
+
"69002-4", # Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
|
|
889
|
+
"691-6", # Neisseria gonorrhoeae [Presence] in Genital specimen by Organism specific culture
|
|
890
|
+
"692-4", # Neisseria gonorrhoeae [Presence] in Genital lochia by Organism specific culture
|
|
891
|
+
"693-2", # Neisseria gonorrhoeae [Presence] in Vaginal fluid by Organism specific culture
|
|
892
|
+
"697-3", # Neisseria gonorrhoeae [Presence] in Urethra by Organism specific culture
|
|
893
|
+
"698-1", # Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
|
|
894
|
+
"70061-7", # Human papilloma virus 16 and 18 DNA [Presence] in Specimen by NAA with probe detection
|
|
895
|
+
"71431-1", # Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detection
|
|
896
|
+
"71793-4", # Treponema pallidum Ab [Titer] in Serum or Plasma by Agglutination
|
|
897
|
+
"73732-0", # Human papilloma virus 26+31+33+35+39+45+51+52+53+56+58+59+66+68+73+82 DNA [Presence] in Genital specimen by NAA with probe detection
|
|
898
|
+
"73959-9", # Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+66 DNA [Presence] in Tissue by Probe
|
|
899
|
+
"75694-0", # Human papilloma virus 18+45 E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
|
|
900
|
+
"77375-4", # Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Specimen by NAA with probe detection
|
|
901
|
+
"77399-4", # Human papilloma virus 16 DNA [Presence] in Cervix by NAA with probe detection
|
|
902
|
+
"77400-0", # Human papilloma virus 18 DNA [Presence] in Cervix by NAA with probe detection
|
|
903
|
+
"7975-6", # Human papilloma virus Ab [Presence] in Genital specimen
|
|
904
|
+
"8041-6", # Treponema pallidum Ab [Presence] in Serum by Hemagglutination
|
|
905
|
+
"82354-2", # Human papilloma virus 16 and 18+45 E6+E7 mRNA [Identifier] in Cervix by NAA with probe detection
|
|
906
|
+
"82456-5", # Human papilloma virus 16 E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
|
|
907
|
+
"82675-0", # Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by NAA with probe detection
|
|
908
|
+
"86560-0", # Human papilloma virus 16 DNA [Presence] in Tissue by NAA with probe detection
|
|
909
|
+
"86561-8", # Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Tissue by NAA with probe detection
|
|
910
|
+
"86562-6", # Human papilloma virus 18 DNA [Presence] in Tissue by NAA with probe detection
|
|
911
|
+
"86563-4", # Human papilloma virus 31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Tissue by NAA with probe detection
|
|
912
|
+
"86564-2", # Human papilloma virus DNA [Presence] in Tissue by NAA with probe detection
|
|
913
|
+
"91073-7", # Human papilloma virus genotype [Identifier] in Tissue by NAA with probe detection
|
|
914
|
+
"91851-6", # Human papilloma virus genotype [Identifier] in Genital specimen by NAA with probe detection
|
|
915
|
+
"91852-4", # Human papilloma virus DNA [Presence] in Genital specimen by NAA with probe detection
|
|
916
|
+
"91854-0", # Human papilloma virus 18 DNA [Presence] in Genital specimen by NAA with probe detection
|
|
917
|
+
"91855-7", # Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Genital specimen by NAA with probe detection
|
|
918
|
+
"91856-5", # Human papilloma virus 16 DNA [Presence] in Genital specimen by NAA with probe detection
|
|
919
|
+
"93777-1", # Human papilloma virus 16+18 E6+E7 mRNA [Presence] in Tissue by Probe
|
|
920
|
+
"93778-9", # Human papilloma virus 6+11 E6+E7 mRNA [Presence] in Tissue by Probe
|
|
921
|
+
"94425-6", # Human papilloma virus E6+E7 mRNA [Presence] in Specimen by NAA with probe detection
|
|
922
|
+
"95533-6", # Human papilloma virus 56+59+66 DNA [Presence] in Cervix by NAA with probe detection
|
|
923
|
+
"95534-4", # Human papilloma virus 52 DNA [Presence] in Cervix by NAA with probe detection
|
|
924
|
+
"95535-1", # Human papilloma virus 51 DNA [Presence] in Cervix by NAA with probe detection
|
|
925
|
+
"95536-9", # Human papilloma virus 45 DNA [Presence] in Cervix by NAA with probe detection
|
|
926
|
+
"95537-7", # Human papilloma virus 35+39+68 DNA [Presence] in Cervix by NAA with probe detection
|
|
927
|
+
"95538-5", # Human papilloma virus 33+58 DNA [Presence] in Cervix by NAA with probe detection
|
|
928
|
+
"95539-3", # Human papilloma virus 31 DNA [Presence] in Cervix by NAA with probe detection
|
|
929
|
+
"9568-7", # Neisseria gonorrhoeae Ab [Titer] in Serum by Complement fixation
|
|
930
|
+
"95938-7", # Fetal Cerebellum Diameter transverse percentile per estimated gestational age
|
|
931
|
+
"95939-5", # Fetal Crown Rump length percentile per estimated gestational age
|
|
932
|
+
"95940-3", # Fetal Head Diameter.biparietal percentile per estimated gestational age
|
|
933
|
+
"96124-3", # Fetal femur diaphysis length percentile per estimated gestational age
|
|
934
|
+
"96125-0", # Fetal Abdomen Circumference Per estimated gestational age
|
|
935
|
+
"96426-2", # Fetal Nasal bone
|
|
936
|
+
"96599-6", # Neisseria gonorrhoeae DNA [Presence] in Cervix by NAA with probe detection
|
|
937
|
+
}
|
|
938
|
+
|
|
939
|
+
|
|
940
|
+
class PregnancyTest(ValueSet):
|
|
941
|
+
"""
|
|
942
|
+
**Clinical Focus:** The purpose of this value set is to represent concepts for pregnancy tests.
|
|
943
|
+
|
|
944
|
+
**Data Element Scope:** This value set may use a model element related to Laboratory Test.
|
|
945
|
+
|
|
946
|
+
**Inclusion Criteria:** Includes concepts that represent tests for pregnancy including in urine, serum or plasma.
|
|
947
|
+
|
|
948
|
+
**Exclusion Criteria:** Excludes concepts that represent an order only.
|
|
949
|
+
|
|
950
|
+
** Used in:** CMS153v10
|
|
951
|
+
"""
|
|
952
|
+
|
|
953
|
+
VALUE_SET_NAME = "Pregnancy Test"
|
|
954
|
+
OID = "2.16.840.1.113883.3.464.1003.111.12.1011"
|
|
955
|
+
DEFINITION_VERSION = "20170504"
|
|
956
|
+
EXPANSION_VERSION = "eCQM Update 2021-05-06"
|
|
957
|
+
|
|
958
|
+
LOINC = {
|
|
959
|
+
"19080-1", # Choriogonadotropin [Units/volume] in Serum or Plasma
|
|
960
|
+
"19180-9", # Choriogonadotropin.beta subunit free [Units/volume] in Serum or Plasma
|
|
961
|
+
"20415-6", # Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma by Immunoassay (EIA) 3rd IS
|
|
962
|
+
"20994-0", # Choriogonadotropin [Interpretation] in Serum or Plasma
|
|
963
|
+
"2106-3", # Choriogonadotropin (pregnancy test) [Presence] in Urine
|
|
964
|
+
"2107-1", # Choriogonadotropin [Moles/volume] in Urine
|
|
965
|
+
"2110-5", # Choriogonadotropin.beta subunit (pregnancy test) [Presence] in Serum or Plasma
|
|
966
|
+
"2111-3", # Choriogonadotropin.beta subunit [Moles/volume] in Serum or Plasma
|
|
967
|
+
"2112-1", # Choriogonadotropin.beta subunit (pregnancy test) [Presence] in Urine
|
|
968
|
+
"2113-9", # Choriogonadotropin.beta subunit [Mass/time] in 24 hour Urine
|
|
969
|
+
"2114-7", # Choriogonadotropin.beta subunit [Moles/volume] in Urine
|
|
970
|
+
"2115-4", # Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
|
|
971
|
+
"2118-8", # Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
|
|
972
|
+
"2119-6", # Choriogonadotropin [Moles/volume] in Serum or Plasma
|
|
973
|
+
"21198-7", # Choriogonadotropin.beta subunit [Units/volume] in Serum or Plasma
|
|
974
|
+
"25372-4", # Choriogonadotropin [Units/volume] in Urine
|
|
975
|
+
"25373-2", # Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
|
|
976
|
+
"34670-0", # Choriogonadotropin [Mass/volume] in Serum or Plasma
|
|
977
|
+
"45194-8", # Choriogonadotropin.intact+Beta subunit [Units/volume] in Serum or Plasma
|
|
978
|
+
"55869-2", # Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
|
|
979
|
+
"55870-0", # Choriogonadotropin [Units/volume] in Cord blood
|
|
980
|
+
"56497-1", # Choriogonadotropin.beta subunit [Units] in 24 hour Urine
|
|
981
|
+
"80384-1", # Choriogonadotropin (pregnancy test) [Presence] in Urine by Rapid immunoassay
|
|
982
|
+
"80385-8", # Choriogonadotropin (pregnancy test) [Presence] in Serum by Rapid immunoassay
|
|
983
|
+
"83086-9", # Choriogonadotropin [Units/volume] in Serum or Plasma by Immunoassay
|
|
984
|
+
"93769-8", # Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
|
|
985
|
+
}
|
|
986
|
+
|
|
987
|
+
|
|
988
|
+
class LaboratoryTestsForHypertension(ValueSet):
|
|
989
|
+
"""
|
|
990
|
+
**Clinical Focus:** The purpose of this value set is to represent concepts for lab tests that are commonly performed on patients with hypertension.
|
|
991
|
+
|
|
992
|
+
**Data Element Scope:** This value set may use a model element related to Laboratory Test.
|
|
993
|
+
|
|
994
|
+
**Inclusion Criteria:** Includes concepts that represent concepts for lab tests that are commonly performed on patients with hypertension.
|
|
995
|
+
|
|
996
|
+
**Exclusion Criteria:** No exclusions.
|
|
997
|
+
|
|
998
|
+
** Used in:** CMS22v10
|
|
999
|
+
"""
|
|
1000
|
+
|
|
1001
|
+
VALUE_SET_NAME = "Laboratory Tests for Hypertension"
|
|
1002
|
+
OID = "2.16.840.1.113883.3.600.1482"
|
|
1003
|
+
DEFINITION_VERSION = "20170504"
|
|
1004
|
+
EXPANSION_VERSION = "eCQM Update 2021-05-06"
|
|
1005
|
+
|
|
1006
|
+
LOINC = {
|
|
1007
|
+
"24320-4", # Basic metabolic 1998 panel - Serum or Plasma
|
|
1008
|
+
"24321-2", # Basic metabolic 2000 panel - Serum or Plasma
|
|
1009
|
+
"24323-8", # Comprehensive metabolic 2000 panel - Serum or Plasma
|
|
1010
|
+
"24356-8", # Urinalysis complete panel - Urine
|
|
1011
|
+
"24357-6", # Urinalysis macro (dipstick) panel - Urine
|
|
1012
|
+
"24362-6", # Renal function 2000 panel - Serum or Plasma
|
|
1013
|
+
"2888-6", # Protein [Mass/volume] in Urine
|
|
1014
|
+
"57021-8", # CBC W Auto Differential panel - Blood
|
|
1015
|
+
"57782-5", # CBC W Ordered Manual Differential panel - Blood
|
|
1016
|
+
"58410-2", # CBC panel - Blood by Automated count
|
|
1017
|
+
}
|
|
1018
|
+
|
|
1019
|
+
|
|
1020
|
+
class LdlCholesterol(ValueSet):
|
|
1021
|
+
"""
|
|
1022
|
+
**Clinical Focus:** The purpose of this value set is to represent concepts for laboratory tests commonly used for low-density lipoproteins (LDL) cholesterol measurement.
|
|
1023
|
+
|
|
1024
|
+
**Data Element Scope:** This value set may use a model element related to Laboratory Test.
|
|
1025
|
+
|
|
1026
|
+
**Inclusion Criteria:** Includes concepts that represent a laboratory test measuring low-density lipoprotein cholesterol (LDL-C) using the specimen type of serum or plasma based on a measurement scale of mass per volume.
|
|
1027
|
+
|
|
1028
|
+
**Exclusion Criteria:** No exclusions.
|
|
1029
|
+
|
|
1030
|
+
** Used in:** CMS347v5
|
|
1031
|
+
"""
|
|
1032
|
+
|
|
1033
|
+
VALUE_SET_NAME = "LDL Cholesterol"
|
|
1034
|
+
OID = "2.16.840.1.113883.3.526.3.1573"
|
|
1035
|
+
DEFINITION_VERSION = "20200307"
|
|
1036
|
+
EXPANSION_VERSION = "eCQM Update 2021-05-06"
|
|
1037
|
+
|
|
1038
|
+
LOINC = {
|
|
1039
|
+
"13457-7", # Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation
|
|
1040
|
+
"18261-8", # Cholesterol in LDL [Mass/volume] in Serum or Plasma ultracentrifugate
|
|
1041
|
+
"18262-6", # Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay
|
|
1042
|
+
"2089-1", # Cholesterol in LDL [Mass/volume] in Serum or Plasma
|
|
1043
|
+
"43394-6", # Cholesterol in LDL acylated [Mass/volume] in Serum or Plasma
|
|
1044
|
+
"49132-4", # Cholesterol in LDL [Mass/volume] in Serum or Plasma by Electrophoresis
|
|
1045
|
+
"50193-2", # Cholesterol in LDL.narrow density [Mass/volume] in Serum or Plasma
|
|
1046
|
+
"55440-2", # Cholesterol.in LDL (real) [Mass/volume] in Serum or Plasma by VAP
|
|
1047
|
+
"86911-5", # Cholesterol in LDL goal [Mass/volume] Serum or Plasma
|
|
1048
|
+
"90364-1", # Cholesterol.in LDL.small dense [Mass/volume] in Serum by Immunoassay
|
|
1049
|
+
"91105-7", # Cholesterol in LDL 1 [Mass/volume] in Serum or Plasma
|
|
1050
|
+
"91106-5", # Cholesterol in LDL 2 [Mass/volume] in Serum or Plasma
|
|
1051
|
+
"91107-3", # Cholesterol in LDL 3 [Mass/volume] in Serum or Plasma
|
|
1052
|
+
"91108-1", # Cholesterol in LDL 4 [Mass/volume] in Serum or Plasma
|
|
1053
|
+
"91109-9", # Cholesterol in LDL 5 [Mass/volume] in Serum or Plasma
|
|
1054
|
+
"91110-7", # Cholesterol in LDL 6 [Mass/volume] in Serum or Plasma
|
|
1055
|
+
"91111-5", # Cholesterol in LDL 7 [Mass/volume] in Serum or Plasma
|
|
1056
|
+
"96259-7", # Cholesterol in LDL [Mass/volume] in Serum or Plasma by Calculated by Martin-Hopkins
|
|
1057
|
+
"96597-0", # Cholesterol in LDL [Mass/volume] in DBS by Direct assay
|
|
1058
|
+
}
|
|
1059
|
+
|
|
1060
|
+
|
|
1061
|
+
class HumanImmunodeficiencyVirusHivLaboratoryTestCodesAbAndAg(ValueSet):
|
|
1062
|
+
"""
|
|
1063
|
+
**Clinical Focus:** The purpose of this value set is to represent concepts for laboratory tests used for Human Immunodeficiency Virus (HIV) screening.
|
|
1064
|
+
|
|
1065
|
+
**Data Element Scope:** This value set may use a model element related to Laboratory Test.
|
|
1066
|
+
|
|
1067
|
+
**Inclusion Criteria:** Includes concepts that represent a laboratory test for HIV-1 and HIV-2 antibodies or antigens.
|
|
1068
|
+
|
|
1069
|
+
**Exclusion Criteria:** Excludes concepts that represent tests and procedures that might be associated with HIV infection but not used for screening or testing to establish an HIV diagnosis such as home/self HIV testing, HIV genotyping tests, HIV RNA tests, HIV cultures, clinical codes used to document care provided to HIV-infected patients.
|
|
1070
|
+
|
|
1071
|
+
** Used in:** CMS349v4
|
|
1072
|
+
"""
|
|
1073
|
+
|
|
1074
|
+
VALUE_SET_NAME = "Human Immunodeficiency Virus (HIV) Laboratory Test Codes (Ab and Ag)"
|
|
1075
|
+
OID = "2.16.840.1.113762.1.4.1056.50"
|
|
1076
|
+
DEFINITION_VERSION = "20210226"
|
|
1077
|
+
EXPANSION_VERSION = "eCQM Update 2021-05-06"
|
|
1078
|
+
|
|
1079
|
+
LOINC = {
|
|
1080
|
+
"10901-7", # HIV 2 gp125 Ab [Presence] in Serum by Immunoblot
|
|
1081
|
+
"10902-5", # HIV 2 gp36 Ab [Presence] in Serum by Immunoblot
|
|
1082
|
+
"11078-3", # HIV 2 gp80 Ab [Presence] in Serum by Immunoblot
|
|
1083
|
+
"11079-1", # HIV 2 p26 Ab [Presence] in Serum by Immunoblot
|
|
1084
|
+
"11080-9", # HIV 2 p53 Ab [Presence] in Serum by Immunoblot
|
|
1085
|
+
"11081-7", # HIV 2 p56 Ab [Presence] in Serum by Immunoblot
|
|
1086
|
+
"11082-5", # HIV 2 p68 Ab [Presence] in Serum by Immunoblot
|
|
1087
|
+
"12855-3", # HIV 1 p23 Ab [Presence] in Serum by Immunoblot
|
|
1088
|
+
"12856-1", # HIV 1 p65 Ab [Presence] in Serum by Immunoblot
|
|
1089
|
+
"12857-9", # HIV 1 p28 Ab [Presence] in Serum by Immunoblot
|
|
1090
|
+
"12858-7", # HIV 1 p32 Ab [Presence] in Serum by Immunoblot
|
|
1091
|
+
"12859-5", # HIV 1 p18 Ab [Presence] in Serum by Immunoblot
|
|
1092
|
+
"12870-2", # HIV 1 gp34 Ab [Presence] in Serum by Immunoblot
|
|
1093
|
+
"12871-0", # HIV 1 p26 Ab [Presence] in Serum by Immunoblot
|
|
1094
|
+
"12872-8", # HIV 1 p15 Ab [Presence] in Serum by Immunoblot
|
|
1095
|
+
"12875-1", # HIV 1 p64 Ab [Presence] in Serum by Immunoblot
|
|
1096
|
+
"12876-9", # HIV 1 p53 Ab [Presence] in Serum by Immunoblot
|
|
1097
|
+
"12893-4", # HIV 1 gp105 Ab [Presence] in Serum by Immunoblot
|
|
1098
|
+
"12894-2", # HIV 1 p68 Ab [Presence] in Serum by Immunoblot
|
|
1099
|
+
"12895-9", # HIV 1 p58 Ab [Presence] in Serum by Immunoblot
|
|
1100
|
+
"13499-9", # HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot
|
|
1101
|
+
"13920-4", # HIV 2 p41 Ab [Presence] in Serum by Immunoblot
|
|
1102
|
+
"14092-1", # HIV 1 Ab [Presence] in Serum by Immunofluorescence
|
|
1103
|
+
"14126-7", # HIV 1 gp120+gp160 Ab [Presence] in Serum by Immunoblot
|
|
1104
|
+
"16132-3", # HIV 1 p15+p18 Ab [Presence] in Serum by Immunoblot
|
|
1105
|
+
"16974-8", # HIV 1 Ab [Presence] in Cerebral spinal fluid
|
|
1106
|
+
"16975-5", # HIV 1 IgG Ab [Presence] in Serum
|
|
1107
|
+
"16976-3", # HIV 1 Ag [Units/volume] in Serum
|
|
1108
|
+
"16977-1", # HIV 1 Ag [Presence] in Cerebral spinal fluid
|
|
1109
|
+
"16978-9", # HIV 1 p24 Ab [Units/volume] in Serum
|
|
1110
|
+
"16979-7", # HIV 1 p24 Ag [Units/volume] in Cerebral spinal fluid
|
|
1111
|
+
"18396-2", # HIV 1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
|
|
1112
|
+
"19110-6", # HIV 1 gp41+gp43 Ab [Presence] in Serum by Immunoblot
|
|
1113
|
+
"21007-0", # HIV 1 Ab [Presence] in Serum from Donor
|
|
1114
|
+
"21331-4", # HIV 1 p24 Ab [Titer] in Serum by Immunoblot
|
|
1115
|
+
"21332-2", # HIV 1 p41 Ab [Titer] in Serum by Immunoblot
|
|
1116
|
+
"21334-8", # HIV 2 gp105 Ab [Presence] in Serum by Immunoblot
|
|
1117
|
+
"21335-5", # HIV 2 gp120 Ab [Presence] in Serum by Immunoblot
|
|
1118
|
+
"21336-3", # HIV 2 gp15 Ab [Presence] in Serum by Immunoblot
|
|
1119
|
+
"21337-1", # HIV 2 gp34 Ab [Presence] in Serum by Immunoblot
|
|
1120
|
+
"21338-9", # HIV 2 p31 Ab [Presence] in Serum by Immunoblot
|
|
1121
|
+
"21339-7", # HIV 2 p55 Ab [Presence] in Serum by Immunoblot
|
|
1122
|
+
"21340-5", # HIV 2 p58 Ab [Presence] in Serum by Immunoblot
|
|
1123
|
+
"22356-0", # HIV 1 Ab [Units/volume] in Serum
|
|
1124
|
+
"22357-8", # HIV 1+2 Ab [Units/volume] in Serum
|
|
1125
|
+
"22358-6", # HIV 2 Ab [Units/volume] in Serum
|
|
1126
|
+
"24012-7", # HIV 1 Ag [Presence] in Serum
|
|
1127
|
+
"28004-0", # HIV 1 IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot
|
|
1128
|
+
"28052-9", # HIV 1 IgG band pattern [Interpretation] in Cerebral spinal fluid by Immunoblot
|
|
1129
|
+
"29327-4", # HIV 1 Ab [Presence] in Body fluid
|
|
1130
|
+
"29893-5", # HIV 1 Ab [Presence] in Serum or Plasma by Immunoassay
|
|
1131
|
+
"30361-0", # HIV 2 Ab [Presence] in Serum or Plasma by Immunoassay
|
|
1132
|
+
"31072-2", # HIV 1 p41 Ab [Presence] in Serum by Immunoblot
|
|
1133
|
+
"31073-0", # HIV 2 Ab band pattern [Interpretation] in Serum by Immunoblot
|
|
1134
|
+
"31201-7", # HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay
|
|
1135
|
+
"31430-2", # HIV 1 IgG Ab [Presence] in Cerebral spinal fluid
|
|
1136
|
+
"32571-2", # HIV 1 Ab [Presence] in Urine by Immunoblot
|
|
1137
|
+
"32602-5", # HIV 1+2 Ab [Presence] in Cerebral spinal fluid
|
|
1138
|
+
"32827-8", # HIV 1 p17+p18 Ab [Presence] in Serum by Immunoblot
|
|
1139
|
+
"32842-7", # HIV 1 p17+p18 Ab [Presence] in Serum
|
|
1140
|
+
"33508-3", # HIV 1 p65+p66 Ab [Presence] in Serum by Immunoblot
|
|
1141
|
+
"33660-2", # HIV 1 p24 Ag [Presence] in Serum or Plasma by Neutralization test
|
|
1142
|
+
"33806-1", # HIV 2 IgG Ab [Presence] in Serum by Immunoblot
|
|
1143
|
+
"33807-9", # HIV 2 IgG Ab [Presence] in Serum
|
|
1144
|
+
"33866-5", # HIV 1 Ab [Presence] in Capillary blood by Immunoassay
|
|
1145
|
+
"34591-8", # HIV 1 Ab [Presence] in Body fluid by Immunoassay
|
|
1146
|
+
"34592-6", # HIV 1 Ab [Presence] in Body fluid by Immunoblot
|
|
1147
|
+
"35437-3", # HIV 1 Ab [Presence] in Saliva (oral fluid) by Immunoassay
|
|
1148
|
+
"35438-1", # HIV 1 Ab [Units/volume] in Saliva (oral fluid) by Immunoassay
|
|
1149
|
+
"35439-9", # HIV 1 Ab [Presence] in Saliva (oral fluid) by Immunoblot
|
|
1150
|
+
"35440-7", # HIV 1 gp160 Ab [Presence] in Saliva (oral fluid) by Immunoblot
|
|
1151
|
+
"35441-5", # HIV 1 gp120 Ab [Presence] in Saliva (oral fluid) by Immunoblot
|
|
1152
|
+
"35442-3", # HIV 1 p66 Ab [Presence] in Saliva (oral fluid) by Immunoblot
|
|
1153
|
+
"35443-1", # HIV 1 p65 Ab [Presence] in Saliva (oral fluid) by Immunoblot
|
|
1154
|
+
"35444-9", # HIV 1 p55 Ab [Presence] in Saliva (oral fluid) by Immunoblot
|
|
1155
|
+
"35445-6", # HIV 1 p51 Ab [Presence] in Saliva (oral fluid) by Immunoblot
|
|
1156
|
+
"35446-4", # HIV 1 gp41 Ab [Presence] in Saliva (oral fluid) by Immunoblot
|
|
1157
|
+
"35447-2", # HIV 1 p31 Ab [Presence] in Saliva (oral fluid) by Immunoblot
|
|
1158
|
+
"35448-0", # HIV 1 p24 Ab [Presence] in Saliva (oral fluid) by Immunoblot
|
|
1159
|
+
"35449-8", # HIV 1 p17 Ab [Presence] in Saliva (oral fluid) by Immunoblot
|
|
1160
|
+
"35450-6", # HIV 1 p18 Ab [Presence] in Saliva (oral fluid) by Immunoblot
|
|
1161
|
+
"35452-2", # HIV 1 gp40 Ab [Presence] in Serum by Immunoblot
|
|
1162
|
+
"35564-4", # HIV 1 p31+p32 Ab [Presence] in Serum by Immunoblot
|
|
1163
|
+
"35565-1", # HIV 1 p40 Ab [Presence] in Serum by Immunoblot
|
|
1164
|
+
"40437-6", # HIV 1 p24 Ab [Presence] in Serum or Plasma by Immunoassay
|
|
1165
|
+
"40438-4", # HIV 1 gp41 Ab [Presence] in Serum or Plasma by Immunoassay
|
|
1166
|
+
"40439-2", # HIV 1 gp120+gp160 Ab [Presence] in Serum or Plasma by Immunoassay
|
|
1167
|
+
"40732-0", # HIV 1 IgG Ab [Presence] in Serum by Immunoblot
|
|
1168
|
+
"40733-8", # HIV 1+2 IgG Ab [Presence] in Serum or Plasma by Immunoassay
|
|
1169
|
+
"41143-9", # HIV 1 Ab [Units/volume] in Saliva (oral fluid)
|
|
1170
|
+
"41144-7", # HIV 1 Ab [Presence] in Saliva (oral fluid)
|
|
1171
|
+
"41145-4", # HIV 1 Ab [Presence] in Capillary blood
|
|
1172
|
+
"41290-8", # HIV 1+2 IgM Ab [Units/volume] in Serum or Plasma by Immunoassay
|
|
1173
|
+
"42339-2", # HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
|
|
1174
|
+
"42600-7", # HIV 1+2 Ab [Presence] in Specimen by Immunoassay
|
|
1175
|
+
"42627-0", # HIV 1 Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
|
|
1176
|
+
"42768-2", # HIV 1 and 2 Ab [Interpretation] in Serum Narrative
|
|
1177
|
+
"43008-2", # HIV 1+2 IgM Ab [Units/volume] in Serum
|
|
1178
|
+
"43009-0", # HIV 1+2 IgG Ab [Presence] in Serum
|
|
1179
|
+
"43010-8", # HIV 1+2 Ab [Presence] in Specimen
|
|
1180
|
+
"43011-6", # HIV 1 p24 Ab [Presence] in Serum
|
|
1181
|
+
"43012-4", # HIV 1 gp41 Ab [Presence] in Serum
|
|
1182
|
+
"43013-2", # HIV 1 gp120+gp160 Ab [Presence] in Serum
|
|
1183
|
+
"43185-8", # HIV 1 and 2 Ab band pattern [Interpretation] in Serum by Immunoblot
|
|
1184
|
+
"43599-0", # HIV 1 Ab [Units/volume] in Serum by Immunofluorescence
|
|
1185
|
+
"44531-2", # HIV 1 Ag [Presence] in Serum from Donor
|
|
1186
|
+
"44532-0", # HIV 1 gp120 Ab [Presence] in Serum
|
|
1187
|
+
"44533-8", # HIV 1+2 Ab [Presence] in Serum from Donor
|
|
1188
|
+
"44607-0", # HIV 1 [Interpretation] in Serum or Plasma by Immunoassay
|
|
1189
|
+
"44872-0", # HIV 1 p24 Ag [Presence] in Serum or Plasma from Donor by Immunoassay
|
|
1190
|
+
"44873-8", # HIV 1+2 Ab [Presence] in Serum by Immunoblot
|
|
1191
|
+
"45212-8", # HIV 2 p31+p34 Ab [Presence] in Serum by Immunoblot
|
|
1192
|
+
"47029-4", # HIV 2 Ab [Presence] in Cerebral spinal fluid by Immunoblot
|
|
1193
|
+
"48345-3", # HIV 1+O+2 Ab [Presence] in Serum or Plasma
|
|
1194
|
+
"48346-1", # HIV 1+O+2 Ab [Units/volume] in Serum or Plasma
|
|
1195
|
+
"49483-1", # HIV 1 [Interpretation] in Serum or Plasma by Immunoassay Narrative
|
|
1196
|
+
"49580-4", # HIV 1+2 Ab [Presence] in Specimen by Rapid immunoassay
|
|
1197
|
+
"49718-0", # HIV 1 p24 Ag [Presence] in Cerebral spinal fluid
|
|
1198
|
+
"49905-3", # HIV 1 Ab [Presence] in Specimen by Rapid immunoassay
|
|
1199
|
+
"49965-7", # Deprecated HIV 1 Ab/HIV 2 Ab Ab [Ratio] in Serum by Immunoblot (IB)
|
|
1200
|
+
"51786-2", # HIV 2 Ab Signal/Cutoff in Serum or Plasma by Immunoassay
|
|
1201
|
+
"51866-2", # Deprecated HIV 1 Ab+Ag [Presence] in Serum
|
|
1202
|
+
"5220-9", # HIV 1 Ab [Units/volume] in Serum or Plasma by Immunoassay
|
|
1203
|
+
"5221-7", # HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot
|
|
1204
|
+
"5222-5", # HIV 1 Ag [Presence] in Serum or Plasma by Immunoassay
|
|
1205
|
+
"5223-3", # HIV 1+2 Ab [Units/volume] in Serum or Plasma by Immunoassay
|
|
1206
|
+
"5224-1", # HIV 2 Ab [Units/volume] in Serum or Plasma by Immunoassay
|
|
1207
|
+
"5225-8", # HIV 2 Ab [Presence] in Serum by Immunoblot
|
|
1208
|
+
"53379-4", # HIV 1 Ab [Presence] in Specimen
|
|
1209
|
+
"53601-1", # HIV 1 p24 Ag [Units/volume] in Serum or Plasma by Immunoassay
|
|
1210
|
+
"54086-4", # HIV 1+2 IgG Ab [Presence] in DBS
|
|
1211
|
+
"56888-1", # HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
|
|
1212
|
+
"57974-8", # HIV 1 Ab [Presence] in Cerebral spinal fluid by Immunoblot
|
|
1213
|
+
"57975-5", # HIV 1+O+2 Ab [Presence] in Body fluid
|
|
1214
|
+
"57976-3", # HIV 2 gp140 Ab [Presence] in Serum by Immunoblot
|
|
1215
|
+
"57977-1", # HIV 2 p16 Ab [Presence] in Serum by Immunoblot
|
|
1216
|
+
"57978-9", # HIV 2 p34 Ab [Presence] in Serum by Immunoblot
|
|
1217
|
+
"58900-2", # HIV 1+2 Ab+HIV1 p24 Ag [Units/volume] in Serum or Plasma by Immunoassay
|
|
1218
|
+
"62456-9", # HIV 2 p15 Ab [Presence] in Serum by Immunoblot
|
|
1219
|
+
"68961-2", # HIV 1 Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
|
|
1220
|
+
"69668-2", # HIV 1 and 2 Ab [Identifier] in Serum or Plasma by Rapid immunoassay
|
|
1221
|
+
"73905-2", # HIV 1+2 IgG Ab [Presence] in Serum or Plasma by Rapid immunoassay
|
|
1222
|
+
"73906-0", # HIV 1+2 IgG Ab [Presence] in Blood by Rapid immunoassay
|
|
1223
|
+
"75622-1", # HIV 1 and 2 tests - Meaningful Use set
|
|
1224
|
+
"75666-8", # HIV 1+2 Ab and HIV1 p24 Ag [Identifier] in Serum, Plasma or Blood by Rapid immunoassay
|
|
1225
|
+
"77685-6", # HIV 1 and 2 IgG Ab [Identifier] in Serum or Plasma by Immunoblot
|
|
1226
|
+
"7917-8", # HIV 1 Ab [Presence] in Serum
|
|
1227
|
+
"7918-6", # HIV 1+2 Ab [Presence] in Serum
|
|
1228
|
+
"7919-4", # HIV 2 Ab [Presence] in Serum
|
|
1229
|
+
"80203-3", # HIV 1 and 2 Ab [Identifier] in Serum, Plasma or Blood by Rapid immunoassay
|
|
1230
|
+
"80387-4", # HIV 1+2 Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
|
|
1231
|
+
"81641-3", # HIV 2 Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
|
|
1232
|
+
"83101-6", # HIV 1+2 Ab and HIV1 p24 Ag panel - Serum or Plasma by Immunoassay
|
|
1233
|
+
"85037-0", # HIV 1 and 2 Ab and HIV 1 p24 Ag panel - Serum or Plasma by Immunoassay
|
|
1234
|
+
"85686-4", # HIV 1 Ab [Presence] in Serum, Plasma or Blood by Immunofluorescence
|
|
1235
|
+
"86233-4", # HIV 1 Ab [Presence] in Serum, Plasma or Blood by Immunoblot
|
|
1236
|
+
"86657-4", # HIV 1 and 2 tests - FPAR 2.0 set
|
|
1237
|
+
"89365-1", # HIV 1 and 2 Ab panel - Serum, Plasma or Blood by Rapid immunoassay
|
|
1238
|
+
"89374-3", # HIV 1 Ab [Presence] in Specimen by Immunoassay
|
|
1239
|
+
"9660-2", # HIV 1 gp160 Ab [Presence] in Serum by Immunoblot
|
|
1240
|
+
"9661-0", # HIV 1 gp120 Ab [Presence] in Serum by Immunoblot
|
|
1241
|
+
"9662-8", # HIV 1 gp41 Ab [Presence] in Serum by Immunoblot
|
|
1242
|
+
"9663-6", # HIV 1 p17 Ab [Presence] in Serum by Immunoblot
|
|
1243
|
+
"9664-4", # HIV 1 p24 Ab [Presence] in Serum by Immunoblot
|
|
1244
|
+
"9665-1", # HIV 1 p24 Ag [Units/volume] in Serum
|
|
1245
|
+
"9666-9", # HIV 1 p31 Ab [Presence] in Serum by Immunoblot
|
|
1246
|
+
"9667-7", # HIV 1 p51 Ab [Presence] in Serum by Immunoblot
|
|
1247
|
+
"9668-5", # HIV 1 p55 Ab [Presence] in Serum by Immunoblot
|
|
1248
|
+
"9669-3", # HIV 1 p66 Ab [Presence] in Serum by Immunoblot
|
|
1249
|
+
"9821-0", # HIV 1 p24 Ag [Presence] in Serum
|
|
1250
|
+
}
|